<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Gastric Cancer via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Gastric Cancer' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Gastric+Cancer&t=Gastric+Cancer&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 16:28:16 +0100</lastBuildDate>
        <item>
            <title>Irregular bowel movement in gastrectomized subjects: bowel habits, stool characteristics, fecal flora, and metabolites</title>
            <link>http://www.medworm.com/index.php?rid=5649036&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fphm383k467723561%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Many gastrectomized patients with irregular bowel movements exhibited significant changes showing impaired intestinal microflora
 and metabolite levels.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-9DOI 10.1007/s10120-011-0129-yAuthors
		Teruaki Aoki, The Jikei University School of Medicine, #303/6-13-7 Honkomagome, Bunkyo-Ku, Tokyo, 113-0021 JapanIchiro Yamaji, Post-gastrectomy Patients’ Association “ALPHA CLUB”, Tokyo, JapanTsuyoshi Hisamoto, Post-gastrectomy Patients’ Association “ALPHA CLUB”, Tokyo, JapanMasanori Sato, Post-gastrectomy Patients’ Association “ALPHA CLUB”, Tokyo, JapanTomoko Matsuda, Post-gastrectomy Patients’ Association “ALPHA CLUB”, Tokyo, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Pr...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649036</comments>
            <pubDate>Thu, 26 Jan 2012 16:46:18 +0100</pubDate>
            <guid isPermaLink="false">5649036</guid>        </item>
        <item>
            <title>ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis</title>
            <link>http://www.medworm.com/index.php?rid=5649035&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy440971g4u7044x3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A combination of the detection of serum anti-Helicobacter pylori antibody and measurement of the level of serum pepsinogens (PG)s, known as the ABC method, has been used in screening for
 gastric cancer. The ABC method has been shown to be useful in urban and/or younger populations. The aim of this study was
 to assess whether this method is applicable for an agricultural population with a high incidence of gastric cancer. In all,
 1048 healthy adults (401 men and 647 women) who participated in a mass survey in April 2005 were examined. Their serum samples
 were tested to determine the prevalence of anti-H. pylori antibody, and the levels of PG I and PG II were also measured to assess the presence of atrophic gastritis. Of the elderly
 subjects born before 1940, 59.4% w...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649035</comments>
            <pubDate>Thu, 26 Jan 2012 16:46:18 +0100</pubDate>
            <guid isPermaLink="false">5649035</guid>        </item>
        <item>
            <title>To resect or not resect in metastatic gastric cancer: that is the question!</title>
            <link>http://www.medworm.com/index.php?rid=5649034&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0k47846752756531%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s10120-011-0136-zAuthors
		Florian Lordick, 3rd Department of Medicine (Hematology and Oncology), Clinic Braunschweig, Celler Str. 38, 38114 Braunschweig, Germany
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649034</comments>
            <pubDate>Thu, 26 Jan 2012 16:46:18 +0100</pubDate>
            <guid isPermaLink="false">5649034</guid>        </item>
        <item>
            <title>A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5639022&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56pv6274220423h8%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our study did not show sufficient prolongation of survival with the concurrent strategy to proceed to a phase-III trial; however,
 the sequential arms showed survival comparable to that in the concurrent arms, with less toxicity. In patients who are ineligible
 for cisplatin (CDDP), sequential treatment starting with S-1 and proceeding to PTX would be a good alternative strategy, considering
 quality of life (QOL) and the cost-benefits of an oral agent as first-line treatment.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0124-3Authors
		Kazuhiro Nishikawa, Department of Surgery, Osaka General Medical Center, 3-1-56 Bandai-higashi, Sumiyoshi-ku, Osaka, 558-8558 JapanSatoshi Morita, Department of Biostatistics and Epidemi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639022</comments>
            <pubDate>Wed, 25 Jan 2012 18:12:35 +0100</pubDate>
            <guid isPermaLink="false">5639022</guid>        </item>
        <item>
            <title>What is the accuracy of sentinel lymph node biopsy for gastric cancer? A systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5620776&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76rn306245100375%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Application of the SLN technique may be practical for early gastric cancer. The use of DUAL for identifying SLN may yield
 a lower FNR than either method alone, although statistical significance was not met.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-12DOI 10.1007/s10120-011-0103-8Authors
		Roberta Cardoso, Division of Surgical Oncology, Sunnybrook Research Institute, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Suite T2-60, 2075 Bayview Ave, Toronto, ON M4N 3M5, CanadaAlina Bocicariu, Division of Surgical Oncology, Sunnybrook Research Institute, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Suite T2-60, 2075 Bayview Ave, Toronto, ON M4N 3M5, CanadaMatthew Dixon, Division of Surgical Oncology, Sunnybrook Research Institu...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620776</comments>
            <pubDate>Fri, 20 Jan 2012 07:07:04 +0100</pubDate>
            <guid isPermaLink="false">5620776</guid>        </item>
        <item>
            <title>Magnifying endoscopy with narrow-band imaging helps determine the management of gastric adenomas</title>
            <link>http://www.medworm.com/index.php?rid=5620777&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16307lg5540h3817%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ME–NBI is useful in planning the management of lesions diagnosed as adenomas by pre-treatment forceps biopsy.
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-5DOI 10.1007/s10120-011-0133-2Authors
		Yosuke Tsuji, Department of Gastroenterology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625 JapanKen Ohata, Department of Gastroenterology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625 JapanMasau Sekiguchi, Department of Gastroenterology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625 JapanAkiko Ohno, Department of Gastroenterology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625 JapanTakafumi Ito, Department of Gastroe...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620777</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:05 +0100</pubDate>
            <guid isPermaLink="false">5620777</guid>        </item>
        <item>
            <title>Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5620778&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg92l284389q6061t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Weekly paclitaxel was modestly active in patients with gastric cancer refractory to docetaxel-based chemotherapy.
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-6DOI 10.1007/s10120-011-0135-0Authors
		Takayuki Ando, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194 JapanAyumu Hosokawa, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194 JapanShinya Kajiura, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194 JapanYuko Itaya, Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 93...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620778</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:04 +0100</pubDate>
            <guid isPermaLink="false">5620778</guid>        </item>
        <item>
            <title>Patient heterogeneity and allocation bias: how should they be reported in clinical trials of chemotherapy for advanced gastric cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5620781&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7321642w88qn7n62%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s10120-011-0130-5Authors
		Ichinosuke Hyodo, Division of Gastroenterology, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305-8575, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620781</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:03 +0100</pubDate>
            <guid isPermaLink="false">5620781</guid>        </item>
        <item>
            <title>Descriptive epidemiology of gastric adenocarcinoma in the State of Texas by ethnicity: Hispanic versus White non-Hispanic</title>
            <link>http://www.medworm.com/index.php?rid=5620780&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpv5505x032530771%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The incidence of gastric adenocarcinoma is higher in Hispanics than in Whites in both El Paso County and the remaining portion
 of Texas. Hispanics have a higher grade of gastric adenocarcinoma. The prevalence of late stage at the time of diagnosis is
 higher in younger patients than in older patients.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-9DOI 10.1007/s10120-011-0127-0Authors
		Babak Rajabi, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USAJavier C. Corral, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USANawar Hakim, Department of Pathology, Paul L. Foster School of Medicine,...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620780</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:03 +0100</pubDate>
            <guid isPermaLink="false">5620780</guid>        </item>
        <item>
            <title>Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5620779&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp133v6x7lu732721%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Vδ1 γδ T cells show decreased frequency and impaired function in gastric cancer tissue, for which decreased NKG2D expression
 might be one of the mechanisms. Modalities specifically targeting NKG2D in Vδ1 γδ T cells may provide a breakthrough treatment
 for gastric cancer patients.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0138-xAuthors
		Hirohiko Kuroda, Division of Surgical Oncology, Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504 JapanHiroaki Saito, Division of Surgical Oncology, Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504 JapanMasahide Ikeguchi, Division of Surgical Oncology, Department of Surgery, Tottori Univ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620779</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:03 +0100</pubDate>
            <guid isPermaLink="false">5620779</guid>        </item>
        <item>
            <title>Vitamin A and gastric cancer risk</title>
            <link>http://www.medworm.com/index.php?rid=5620782&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63876t387n677870%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s10120-011-0137-yAuthors
		Levent Filik, Gastroenterology Division, Ankara Research Hospital, Ulucanlar, Altindag, Ankara 06600, Turkey
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620782</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:02 +0100</pubDate>
            <guid isPermaLink="false">5620782</guid>        </item>
        <item>
            <title>Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute</title>
            <link>http://www.medworm.com/index.php?rid=5620783&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw742440m42438073%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Early detection and curative operations are essential for improving the prognosis of gastric EC. However, some adjuvant chemotherapies
 are required for advanced-stage tumors. Classification and staging systems may need to be unified worldwide for further analysis.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0122-5Authors
		Takeshi Kubota, Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550 JapanShigekazu Ohyama, Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550 JapanNaoki Hiki, Department of Gastroenterological Surgery, C...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620783</comments>
            <pubDate>Wed, 18 Jan 2012 06:52:01 +0100</pubDate>
            <guid isPermaLink="false">5620783</guid>        </item>
        <item>
            <title>Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5583184&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7530442475578h39%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;mFOLFOX6 maintains its efficacy and safety in elderly patients aged over 65&amp;nbsp;years in comparison with AGC patients aged &amp;lt;65
 years. Its judicious use should be considered regardless of age.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0128-zAuthors
		Yo Han Cho, Department of Hemato-oncology, Konkuk University Medical Center, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, 143-729 Republic of KoreaSung Yong Kim, Department of Hemato-oncology, Konkuk University Medical Center, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, 143-729 Republic of KoreaM. Hong Lee, Department of Hemato-oncology, Konkuk University Medical Center, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, 143-729 Republic of KoreaMoon-Won Yoo, Department of General Surgery...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583184</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:12 +0100</pubDate>
            <guid isPermaLink="false">5583184</guid>        </item>
        <item>
            <title>Adenovirus-mediated expression of p33ING1b induces apoptosis and inhibits proliferation in gastric adenocarcinoma cells in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5583183&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffnv306x021200917%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Down-regulation of p33ING1b might play an important role in the development of gastric adenocarcinoma. Targeted local expression of p33ING1b may offer a promising alternative therapeutic measure for gastric cancer.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0123-4Authors
		Yifei Lv, Department of Gastroenterology, 1st Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, 710061 Xi’an, ChinaBibek Kumar Purbey, Department of Gastroenterology, 1st Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, 710061 Xi’an, ChinaYanhua Huang, Department of Gastroenterology, 1st Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, 710061 Xi’an, ChinaShuang Li, Department of Ga...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583183</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:12 +0100</pubDate>
            <guid isPermaLink="false">5583183</guid>        </item>
        <item>
            <title>Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study</title>
            <link>http://www.medworm.com/index.php?rid=5583182&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp26115357w081167%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;For patients with metastatic gastric cancer, the sequential administration of cisplatin, leucovorin, 5-FU, and docetaxel may
 be an effective palliative option and offers a far more favorable toxicity profile than the simultaneous use of docetaxel,
 cisplatin, and 5-FU.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s10120-011-0134-1Authors
		Vincenzo Catalano, U.O.C. Oncologia, Azienda Ospedaliera “Ospedali Riuniti Marche Nord”, Presidio San Salvatore, Via Lombroso, 61122 Pesaro, ItalyBruno Vincenzi, Oncologia Medica, Università Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, ItalyPaolo Giordani, U.O.C. Oncologia, Azienda Ospedaliera “Ospedali Riuniti Marche Nord”, Presidio San Salvatore, Via Lombroso, 61122 P...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583182</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:12 +0100</pubDate>
            <guid isPermaLink="false">5583182</guid>        </item>
        <item>
            <title>A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5583185&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe76j733809115511%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;EUS is a moderately accurate technique that seems to describe advanced T stage (T3 and T4) better than N or less advanced
 T stage. Stratifying by EUS annual volume did not affect EUS performance in staging gastric cancer.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-8DOI 10.1007/s10120-011-0115-4Authors
		Roberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaNatalie Coburn, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRinku Sutradhar, Institute for Clinical Evaluative Sciences, Toronto, CanadaLaercio Gomes Lourenco, Department of Surgery, Federal University of Sao Pa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583185</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:10 +0100</pubDate>
            <guid isPermaLink="false">5583185</guid>        </item>
        <item>
            <title>Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection</title>
            <link>http://www.medworm.com/index.php?rid=5583187&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1hn4175830p2m42%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We identified seven novel gastric cancer risk markers that are highly informative in individuals with past infection.
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0126-1Authors
		Sohachi Nanjo, Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKiyoshi Asada, Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanSatoshi Yamashita, Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTakeshi Nakajima, Gastrointestinal Endoscopy Division, National Cancer Center Hospital, Tokyo, JapanKazuyuki Nakazawa, Second Department of Internal Medicine, Waka...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583187</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:09 +0100</pubDate>
            <guid isPermaLink="false">5583187</guid>        </item>
        <item>
            <title>A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach</title>
            <link>http://www.medworm.com/index.php?rid=5583186&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw70788t47m3m3851%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The MAb MUC1-014E is very useful for accurate detection of isolated cancer cells in scirrhous gastric cancers.
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s10120-011-0125-2Authors
		Suguru Yonezawa, Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8544 JapanShinichi Kitajima, Department of Surgical Pathology, Kagoshima University Hospital, Kagoshima, JapanMichiyo Higashi, Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8544 JapanMasahiko Osako, Department of Surgery, Kagoshima-shi Medical Association Hospital, Kagoshima, J...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5583186</comments>
            <pubDate>Wed, 11 Jan 2012 17:52:09 +0100</pubDate>
            <guid isPermaLink="false">5583186</guid>        </item>
        <item>
            <title>Authors’ reply: Should we inherit bursectomy or discard it?</title>
            <link>http://www.medworm.com/index.php?rid=5525873&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmvw7vl743648j73n%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s10120-011-0119-0Authors
		Junya Fujita, Department of Surgery, Toyonaka Municipal Hospital, Osaka, JapanYukinori Kurokawa, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanShuji Takiguchi, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanYuichiro Doki, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5525873</comments>
            <pubDate>Mon, 19 Dec 2011 16:53:02 +0100</pubDate>
            <guid isPermaLink="false">5525873</guid>        </item>
        <item>
            <title>Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study</title>
            <link>http://www.medworm.com/index.php?rid=5515928&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr37633583u3gww34%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;After adjusting for imbalanced patient backgrounds between arms, overall survival of Japanese patients with human epidermal
 growth factor 2 positive advanced/metastatic gastric or gastroesophageal junction cancer who received trastuzumab plus chemotherapy
 was improved compared with patients who received chemotherapy alone.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-10DOI 10.1007/s10120-011-0118-1Authors
		Akira Sawaki, Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanYasuo Ohashi, Department of Biostatistics, Public Health Research Foundation, Tokyo, JapanYasushi Omuro, Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanTaroh Satoh, Department of Med...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515928</comments>
            <pubDate>Fri, 16 Dec 2011 16:54:47 +0100</pubDate>
            <guid isPermaLink="false">5515928</guid>        </item>
        <item>
            <title>The potential value of bursectomy in operations for trans-serosal gastric adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5505914&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F370xq426634u4176%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s10120-011-0121-6Authors
		Scott A. Hundahl, Sacramento VA at Mather, VA Northern California Health Care System, University of California at Davis, 10535 Hospital Way (112), Mather, CA 95655-1200, USA
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5505914</comments>
            <pubDate>Mon, 12 Dec 2011 17:15:41 +0100</pubDate>
            <guid isPermaLink="false">5505914</guid>        </item>
        <item>
            <title>Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients</title>
            <link>http://www.medworm.com/index.php?rid=5495368&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr2x5176557189872%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A 3-week regimen of S-1 plus cisplatin was active and well tolerated as first-line treatment in patients with AGC. Disease
 status and bone metastasis were the most important prognostic factors.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0117-2Authors
		Dong Hoe Koo, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736 KoreaMin-Hee Ryu, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736 KoreaBaek-Yeol Ryoo, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736 KoreaSung-Sook Le...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495368</comments>
            <pubDate>Fri, 09 Dec 2011 17:05:24 +0100</pubDate>
            <guid isPermaLink="false">5495368</guid>        </item>
        <item>
            <title>A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5495369&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1333p6x7n25j404k%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;CDH1 mutation testing in families with a history of gastric cancer and prophylactic gastrectomy in mutation-positive patients
 are recommended for the management of HDGC.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-11DOI 10.1007/s10120-011-0116-3Authors
		Rajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaNatalie Coburn, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaMatthew Dixon, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaAlina Bocicariu, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaLucy Hel...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495369</comments>
            <pubDate>Fri, 09 Dec 2011 17:05:22 +0100</pubDate>
            <guid isPermaLink="false">5495369</guid>        </item>
        <item>
            <title>A meta-analysis of D1 versus D2 lymph node dissection</title>
            <link>http://www.medworm.com/index.php?rid=5477250&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff721n8l551r31507%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Earlier trials show that D2 dissections have higher operative mortality, while recent trials have similar rates. A trend of
 improved survival exists among D2 patients who did not undergo resection of the spleen or pancreas, as well as for patients
 with T3/T4 cancers.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-10DOI 10.1007/s10120-011-0110-9Authors
		Rajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaAlina Bocicariu, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaAlyson Mahar, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaAlex Ki...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477250</comments>
            <pubDate>Fri, 02 Dec 2011 17:13:54 +0100</pubDate>
            <guid isPermaLink="false">5477250</guid>        </item>
        <item>
            <title>Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival</title>
            <link>http://www.medworm.com/index.php?rid=5477249&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp217812531328711%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The probability of acquiring positive margins is highly dependent on the biology and the extent of the tumor. There is a significant
 negative effect on survival, which is more prominent in cancers at early stages, making re-resection or a second operation
 important. Patients with more advanced disease can be offered more extensive surgery to remove disease, but this should be
 balanced against the risks of more extensive resections.
 
 
 
 
	Content Type Journal ArticleCategory Review ArticlePages 1-9DOI 10.1007/s10120-011-0112-7Authors
		Hamid Reza Raziee, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRajini Seevaratnam, Sunnybrook R...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477249</comments>
            <pubDate>Fri, 02 Dec 2011 17:13:54 +0100</pubDate>
            <guid isPermaLink="false">5477249</guid>        </item>
        <item>
            <title>Screening and minimally invasive treatment for gastric cancer are important challenges in elderly patients</title>
            <link>http://www.medworm.com/index.php?rid=5477248&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp75178q12j62v000%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s10120-011-0120-7Authors
		Osamu Hosokawa, Yokohama Sakae Kyosai Hospital, Yokohama, Kanagawa, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477248</comments>
            <pubDate>Fri, 02 Dec 2011 17:13:54 +0100</pubDate>
            <guid isPermaLink="false">5477248</guid>        </item>
        <item>
            <title>CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5409397&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F35276184124083px%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The density of CD83+ DCs and Foxp3+ Tregs was inversely correlated with tumor progression and reflected the prognosis of gastric cancer.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-10DOI 10.1007/s10120-011-0090-9Authors
		Seigo Kashimura, Department of Surgery I, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295 JapanZenichiro Saze, Department of Surgery I, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295 JapanMasanori Terashima, Gastric Surgery Division, Shizuoka Cancer Center, Shizuoka, JapanNobutoshi Soeta, Department of Surgery I, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295 JapanSatoshi Ohtani, Department of Surgery I, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295 Japa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409397</comments>
            <pubDate>Mon, 14 Nov 2011 16:54:29 +0100</pubDate>
            <guid isPermaLink="false">5409397</guid>        </item>
        <item>
            <title>A case of lymph node metastasis following a curative endoscopic submucosal dissection of an early gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5409396&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb3x8388475777t16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Currently in Japan, differentiated gastric submucosal invasive cancers &amp;lt;500&amp;nbsp;μm (SM1) with negative lymphovascular involvement
 are included in expanded pathological criteria for curative endoscopic treatment. This is based on a retrospective examination
 of surgical resection cases in which patients suitable for such expanded criteria were determined to have a negligible risk
 of lymph node metastasis. We performed endoscopic submucosal dissection on a 65-year-old male with early gastric cancer in
 April 2005, and pathology revealed a well-differentiated adenocarcinoma, 21&amp;nbsp;×&amp;nbsp;10&amp;nbsp;mm in size, SM1 invasion depth and negative
 lymphovascular invasion as well as tumor-free margins, so the case was diagnosed as a curative resection. This case, however,...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409396</comments>
            <pubDate>Mon, 14 Nov 2011 16:54:29 +0100</pubDate>
            <guid isPermaLink="false">5409396</guid>        </item>
        <item>
            <title>Adenocarcinoma arising in an intramural diverticulum presenting as a long-standing submucosal tumor</title>
            <link>http://www.medworm.com/index.php?rid=5409399&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2043vr364481t05%2F</link>
            <description>We report a rare case of adenocarcinoma arising in a gastric partial diverticulum in the upper portion of the stomach. The
 lesion had been followed up for approximately 14&amp;nbsp;years as a gastric submucosal tumor. However, a recent regular check-up revealed
 mucous material with some neoplastic tissue discharged from the top of the lesion. A surgically resected specimen showed a
 well-demarcated submucosal lesion identical to a pseudo-diverticulum carrying a distinctive intramucosal minimally invasive
 adenocarcinoma in part, with surrounding non-neoplastic but hyperplastic mucosal components. Intestinal phenotype, along with
 gastric foveolar, pyloric gland-type phenotypes, and neoplastic cells with neuroendocrine differentiation, were also identified
 in the adenocarcinoma. Chronic and ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409399</comments>
            <pubDate>Mon, 14 Nov 2011 16:54:28 +0100</pubDate>
            <guid isPermaLink="false">5409399</guid>        </item>
        <item>
            <title>Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life</title>
            <link>http://www.medworm.com/index.php?rid=5409398&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftp48270680m622j4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;After the early postoperative period and before achieving long-term survival, patients who underwent laparoscopy-assisted
 distal gastrectomy appeared to experience lower quality of life compared to patients who underwent open distal subtotal gastrectomy.
 This finding may be associated with the patients’ erroneously high expectations of laparoscopy-assisted distal gastrectomy.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-6DOI 10.1007/s10120-011-0113-6Authors
		Seung Soo Lee, Department of Surgery, Keimyung University School of Medicine, 194 Dongsan-dong Jung-gu, Daegu, 700-712 The Republic of KoreaSeung Wan Ryu, Department of Surgery, Keimyung University School of Medicine, 194 Dongsan-dong Jung-gu, Daegu, 700-712 The Republic of KoreaIn Ho...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5409398</comments>
            <pubDate>Mon, 14 Nov 2011 16:54:28 +0100</pubDate>
            <guid isPermaLink="false">5409398</guid>        </item>
        <item>
            <title>The flow angle beneath the gastrojejunostomy predicts delayed gastric emptying in Roux-en-Y reconstruction after distal gastrectomy</title>
            <link>http://www.medworm.com/index.php?rid=5388444&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv2547r5535348780%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings demonstrate the substantial benefits of a straight anastomosis of the gastrojejunostomy for the prevention of
 Roux stasis syndrome.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-6DOI 10.1007/s10120-011-0107-4Authors
		Toshihiko Masui, Department of Surgery, Shimane Prefectural Central Hospital, 4-1-1 Himebara, Izumo, Shimane 693-8555, JapanToyonari Kubora, Department of Surgery, Shimane Prefectural Central Hospital, 4-1-1 Himebara, Izumo, Shimane 693-8555, JapanYasutaka Nakanishi, Department of Surgery, Shimane Prefectural Central Hospital, 4-1-1 Himebara, Izumo, Shimane 693-8555, JapanKeiko Aoki, Department of Surgery, Shimane Prefectural Central Hospital, 4-1-1 Himebara, Izumo, Shimane 693-8555, JapanShinichi Sugimoto, Departme...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388444</comments>
            <pubDate>Tue, 01 Nov 2011 05:54:47 +0100</pubDate>
            <guid isPermaLink="false">5388444</guid>        </item>
        <item>
            <title>The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5388445&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp8q80045j4795368%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Since all 27 lymph nodes in 15 patients with metastasis by IHC staining but not by HE staining were micrometastasis or less
 and included in the SN, ICG-positive lymphatic basin dissection by SNNS with infrared ray observation seems to be an adequate
 method of lymph node dissection for gastric cancer.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-5DOI 10.1007/s10120-011-0105-6Authors
		Kentaro Yano, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461 JapanHiroshi Nimura, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461 JapanNorio Mitsumori, Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5388445</comments>
            <pubDate>Mon, 31 Oct 2011 17:00:48 +0100</pubDate>
            <guid isPermaLink="false">5388445</guid>        </item>
        <item>
            <title>Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome</title>
            <link>http://www.medworm.com/index.php?rid=5362384&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0077826v482kl03%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The most frequently observed pattern of lung metastasis was hematogenous metastasis (52.3%) followed by pleural (35.2%) and
 lymphangitic (26.4%) in gastric cancer patients. Among gastric cancer patients with lung metastases, patients with pleural
 metastasis or lymphangitic metastasis had shorter survival with 1.5–2-fold increased risk of deaths.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0104-7Authors
		Jee Hyun Kong, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, 135-710 KoreaJeeyun Lee, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, 135-710 KoreaChin-A Yi, Department of Radiology, S...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362384</comments>
            <pubDate>Sat, 29 Oct 2011 05:48:59 +0100</pubDate>
            <guid isPermaLink="false">5362384</guid>        </item>
        <item>
            <title>Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study</title>
            <link>http://www.medworm.com/index.php?rid=5362385&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk22217q71t470116%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Secondary gastrectomy following S-1-based chemotherapy was a safe and effective treatment for stage IV gastric cancer. Primary
 tumor size is an indicator for the appropriate selection of patients for this treatment.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-10DOI 10.1007/s10120-011-0100-yAuthors
		Tatsuo Kanda, Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi-dori 1-757, Niigata, 951-8510 JapanKazuhito Yajima, Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi-dori 1-757, Niigata, 951-8510 JapanShin-ichi Kosugi, Division of Digestive and General Surgery, Niigata University Graduate School of Medical...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362385</comments>
            <pubDate>Thu, 27 Oct 2011 15:45:23 +0100</pubDate>
            <guid isPermaLink="false">5362385</guid>        </item>
        <item>
            <title>A systematic review of surgery for non-curative gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5362386&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fal72219417g272m4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A lack of transparent documentation of disease burden and symptoms limits the surgical literature in non-curative gastric
 cancer. Improved survival is not evident for all patients receiving non-curative gastrectomy. Further prospective research
 is required to determine the optimal intervention for palliative gastric cancer patients.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-13DOI 10.1007/s10120-011-0088-3Authors
		Alyson L. Mahar, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaNatalie G. Coburn, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaSimron Singh, Department of Medical Oncology/Hematology, Sunnybrook Health Sciences Centre and Odette Cancer Centre, Toronto, CanadaC...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5362386</comments>
            <pubDate>Thu, 27 Oct 2011 15:45:21 +0100</pubDate>
            <guid isPermaLink="false">5362386</guid>        </item>
        <item>
            <title>In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype</title>
            <link>http://www.medworm.com/index.php?rid=5336900&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F402tg5l61k13021t%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Cetuximab is effective in K-ras wild-type, EGFR-expressing gastric cancer cell lines and xenografts. In vivo, the combination
 of cetuximab with carboplatin displayed synergistic antitumor activity.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-13DOI 10.1007/s10120-011-0102-9Authors
		Birgit Hotz, Department of Surgery, Charité-School of Medicine, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, GermanyUlrich Keilholz, Department of Hematology and Oncology, Charité-Medical School Berlin, Campus Benjamin Franklin, Berlin, GermanyAlberto Fusi, Department of Hematology and Oncology, Charité-Medical School Berlin, Campus Benjamin Franklin, Berlin, GermanyHeinz J. Buhr, Department of Surgery, Charité-School of Medicine, Campus Benjami...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5336900</comments>
            <pubDate>Wed, 19 Oct 2011 15:52:43 +0100</pubDate>
            <guid isPermaLink="false">5336900</guid>        </item>
        <item>
            <title>Predicted morbidity and mortality in major gastroenterological surgery</title>
            <link>http://www.medworm.com/index.php?rid=5324531&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F046644p02700qg31%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s10120-011-0108-3Authors
		Asgaut Viste, Department of Gastroenterological and Acute Surgery, Haukeland University Hospital, Bergen, Norway
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324531</comments>
            <pubDate>Fri, 14 Oct 2011 15:44:29 +0100</pubDate>
            <guid isPermaLink="false">5324531</guid>        </item>
        <item>
            <title>A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT</title>
            <link>http://www.medworm.com/index.php?rid=5316206&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe47628631718rv54%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The B-I and R-Y techniques were generally equivalent in terms of postoperative QOL and dysfunction. Both procedures seem acceptable
 as standard reconstructions after distal gastrectomy with regard to postoperative QOL and dysfunction.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0098-1Authors
		Shuji Takiguchi, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0876, JapanKazuyoshi Yamamoto, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0876, JapanMotohiro Hirao, Department of Surgery, Osaka National Hospital, Osaka, JapanHiroshi Imamura, Department of Surgery, Sakai Municipa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316206</comments>
            <pubDate>Wed, 12 Oct 2011 16:05:33 +0100</pubDate>
            <guid isPermaLink="false">5316206</guid>        </item>
        <item>
            <title>Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat</title>
            <link>http://www.medworm.com/index.php?rid=5316208&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv1664711403w2504%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Excessive visceral fat, represented by the VFA, was found to be an independent risk factor for both pancreas-related infection
 and anastomotic leakage following gastrectomy.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0099-0Authors
		Norihiko Sugisawa, Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777 JapanMasanori Tokunaga, Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777 JapanYutaka Tanizawa, Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777 JapanEtsuro Bando, Division of Gastric Surgery, Shizuoka Cancer Center, 1...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316208</comments>
            <pubDate>Wed, 12 Oct 2011 16:05:31 +0100</pubDate>
            <guid isPermaLink="false">5316208</guid>        </item>
        <item>
            <title>Clinical and therapeutic relevance of PIM1 kinase in gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5316207&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5125h84wv5106224%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our findings demonstrate the clinical and therapeutic relevance of PIM1 in gastric cancers, and suggest that PIM1 represents
 a potential therapeutic target.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-10DOI 10.1007/s10120-011-0097-2Authors
		Benedict Yan, Department of Pathology, National University Health System and National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074 SingaporeEe Xuan Yau, Cancer Science Institute, National University of Singapore, Singapore, SingaporeSanjay Samanta, Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore, 117543 SingaporeChee Wee Ong, Cancer Science Institute, National University of Singapore, Singapore, SingaporeKol Jia Yong, Cancer Science Institute...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316207</comments>
            <pubDate>Wed, 12 Oct 2011 16:05:31 +0100</pubDate>
            <guid isPermaLink="false">5316207</guid>        </item>
        <item>
            <title>Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis</title>
            <link>http://www.medworm.com/index.php?rid=5316209&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F45675727r338nj66%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;S-1 plus cisplatin is effective for patients with gastric cancer that recurs after adjuvant S-1 chemotherapy, especially for
 those with an RFI of ≥6&amp;nbsp;months.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-7DOI 10.1007/s10120-011-0101-xAuthors
		Kohei Shitara, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, JapanSatoshi Morita, Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, JapanKazumasa Fujitani, Department of Surgical Oncology, National Osaka Medical Center, Suita, JapanShigenori Kadowaki, Department of Gastroenterology, Saitama Cancer Center Hospital, Saitama, JapanNobuhiro Takiguchi, Department of Gastroenterological Sur...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316209</comments>
            <pubDate>Wed, 12 Oct 2011 16:05:29 +0100</pubDate>
            <guid isPermaLink="false">5316209</guid>        </item>
        <item>
            <title>Clinicopathological features of stomach cancer with invasive micropapillary component</title>
            <link>http://www.medworm.com/index.php?rid=5316210&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnxt024120828j227%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients with gastric cancer with a regional invasive micropapillary component showed marked cancer infiltration in the lymphatic
 pathway and poor prognosis after gastrectomy.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-9DOI 10.1007/s10120-011-0094-5Authors
		Takeo Fujita, Division of Digestive Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, JapanNaoto Gotohda, Division of Digestive Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, JapanYuichiro Kato, Division of Digestive Surgery, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, JapanTakahiro Kinoshita, Division of Digestive Surgery, National Cancer Center Hospital East, 6-5...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316210</comments>
            <pubDate>Tue, 11 Oct 2011 05:52:28 +0100</pubDate>
            <guid isPermaLink="false">5316210</guid>        </item>
        <item>
            <title>Surgical management of gastric perforation in the setting of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5305108&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh04225678788857l%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Gastric cancer patients presenting with a gastric perforation demonstrate improved overall survival with an R0 resection;
 however, implementation of this management technique is complicated by infrequent preoperative gastric cancer diagnosis, and
 inability to perform an oncologic resection due to patient instability and intra-abdominal contamination.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-7DOI 10.1007/s10120-011-0095-4Authors
		Alyson L. Mahar, Department of Community Health and Epidemiology, Queen’s University, Kingston, CanadaSavtaj S. Brar, Division of Surgical Oncology, Sunnybrook Health Sciences Centre and Odette Cancer Centre, Toronto, CanadaNatalie G. Coburn, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Tor...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305108</comments>
            <pubDate>Fri, 07 Oct 2011 15:58:34 +0100</pubDate>
            <guid isPermaLink="false">5305108</guid>        </item>
        <item>
            <title>Does the risk of stomach cancer remain among second-generation immigrants in Sweden?</title>
            <link>http://www.medworm.com/index.php?rid=5286409&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4019q41670l4r8p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The observed increased risks of noncardia stomach cancer among foreign-born second-generation immigrants compared to the Swedes
 suggest that these immigrants were infected by Helicobacter pylori before immigration.
 
 
	Content Type Journal ArticleCategory Short communicationPages 1-3DOI 10.1007/s10120-011-0096-3Authors
		Seyed Mohsen Mousavi, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), CO50, Im Neuenheimer Feld 580, 69120 Heidelberg, GermanyKristina Sundquist, Center for Primary Health Care Research, Lund University, Malmö, SwedenKari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), CO50, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
	

	
		Journal Gastric CancerOnline ISSN 1436-330...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5286409</comments>
            <pubDate>Sat, 01 Oct 2011 06:45:48 +0100</pubDate>
            <guid isPermaLink="false">5286409</guid>        </item>
        <item>
            <title>Delayed perforation occurring after endoscopic submucosal dissection for early gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5251413&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp476818254888631%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Delayed perforation occurring after endoscopic submucosal dissection (ESD) is a rare but serious complication which sometimes
 requires emergent surgery. However, reports of its characteristics, including endoscopic imaging and management, are not fully
 detailed. A 70-year-old woman was referred to our hospital for the treatment of early gastric cancer. On the day of the ESD,
 hematemesis was observed because of a Mallory–Weiss tear, and a visible vessel in the post-ESD ulcer was additionally treated
 endoscopically by coagulation. Second-look endoscopic examination on the next day revealed a perforation 3&amp;nbsp;mm in diameter
 at the treated vessel in the ulcer. The shape of the perforation was round and the color of the surrounding muscle layer had
 become whitish. ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5251413</comments>
            <pubDate>Fri, 23 Sep 2011 05:53:51 +0100</pubDate>
            <guid isPermaLink="false">5251413</guid>        </item>
        <item>
            <title>Dietary vitamin A intake and incidence of gastric cancer in a general Japanese population: the Hisayama Study</title>
            <link>http://www.medworm.com/index.php?rid=5251412&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy23013m74xm31314%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings suggest that dietary vitamin A intake is clearly associated with the risk of gastric cancer in the general Japanese
 population.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0092-7Authors
		Masashi Miyazaki, Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanYasufumi Doi, Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanFumie Ikeda, Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanToshiharu Ninomiya, Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanJun Hata, Department of Envi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5251412</comments>
            <pubDate>Fri, 23 Sep 2011 05:53:51 +0100</pubDate>
            <guid isPermaLink="false">5251412</guid>        </item>
        <item>
            <title>A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5226999&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm831002763223584%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Preservation of the spleen and pancreas during extended lymphadenectomy for gastric cancer decreases complications with no
 clear evidence of improvement or detriment to overall survival.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-11DOI 10.1007/s10120-011-0087-4Authors
		Savtaj S. Brar, Division of Surgical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Suite T2-60, 2075 Bayview Ave, Toronto, ON M4N-3M5, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaCalvin Law, Division of Surgical Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Suite T2-60, 2075 B...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5226999</comments>
            <pubDate>Wed, 14 Sep 2011 05:52:27 +0100</pubDate>
            <guid isPermaLink="false">5226999</guid>        </item>
        <item>
            <title>Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry</title>
            <link>http://www.medworm.com/index.php?rid=5209899&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4773547069um11u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Japanese Gastric Cancer Association (JGCA) started a new nationwide gastric cancer registry in 2008. Approximately 50
 data items, including surgical procedures, pathological diagnoses, and survival outcomes, for 12004 patients with primary
 gastric cancer treated in 2001 were collected retrospectively from 187 participating hospitals. Data were entered into the
 JGCA database according to the JGCA Classification of gastric carcinoma, 13th edition and the International Union Against Cancer (UICC) TNM Classification of malignant tumors, 5th edition by using an electronic data collecting system. Finally, data of 11261 patients with gastric resection were analyzed. The
 5-year follow-up rate was 83.5%. The direct death rate was 0.6%. TNM 5-year survival rates (5YSRs)/J...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209899</comments>
            <pubDate>Tue, 06 Sep 2011 05:48:49 +0100</pubDate>
            <guid isPermaLink="false">5209899</guid>        </item>
        <item>
            <title>Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination</title>
            <link>http://www.medworm.com/index.php?rid=5209900&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa345365k352h1632%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Serum CA125 and CA72-4 are clinically useful markers in diagnosis, evaluating the efficacy of chemotherapy, and predicting
 the prognosis of patients with peritoneal dissemination. From an academic point of view, periodic measurements of these markers
 are warranted in gastric cancer patients with possible peritoneal dissemination.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-8DOI 10.1007/s10120-011-0091-8Authors
		Shigenobu Emoto, Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanHironori Ishigami, Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanHiroharu Yamashita, Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5209900</comments>
            <pubDate>Sun, 04 Sep 2011 10:45:47 +0100</pubDate>
            <guid isPermaLink="false">5209900</guid>        </item>
        <item>
            <title>Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature</title>
            <link>http://www.medworm.com/index.php?rid=5196955&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw340833015314580%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Liver resection in patients with hepatic metastasized gastric cancer is beneficial and safe if an R0 situation can be achieved.
 RFA might be a useful alternative in those patients where surgery is not feasible.
 
 
 
 
	Content Type Journal ArticleCategory Original articlePages 1-6DOI 10.1007/s10120-011-0080-yAuthors
		Yves Dittmar, Department of General, Visceral and Vascular Surgery, University of Jena, Erlanger Allee 101, 07740 Jena, GermanyAnnelore Altendorf-Hofmann, Department of General, Visceral and Vascular Surgery, University of Jena, Erlanger Allee 101, 07740 Jena, GermanyFalk Rauchfuss, Department of General, Visceral and Vascular Surgery, University of Jena, Erlanger Allee 101, 07740 Jena, GermanyMax Götz, Department of General, Visceral and Vascular Su...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5196955</comments>
            <pubDate>Sat, 03 Sep 2011 06:39:46 +0100</pubDate>
            <guid isPermaLink="false">5196955</guid>        </item>
        <item>
            <title>Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5170819&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp540632473720214%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;PD for gastric cancer invading the pancreas is associated with a higher morbidity; given the heterogeneous data, defining
 exact selection criteria is difficult.
 
 
 
 
	Content Type Journal ArticleCategory Review articlePages 1-8DOI 10.1007/s10120-011-0086-5Authors
		Patrick Roberts, Division of General Surgery, University of Toronto, Toronto, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaCalvin Law, Division of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, CanadaLucy Helyer, Division of General Surgery, Department of Surgery, Dalhousie University, Halifax, CanadaNatalie Coburn, D...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5170819</comments>
            <pubDate>Thu, 25 Aug 2011 15:51:56 +0100</pubDate>
            <guid isPermaLink="false">5170819</guid>        </item>
        <item>
            <title>An additional suture secures against pitfalls in delta-shaped gastroduodenostomy after laparoscopic distal gastrectomy</title>
            <link>http://www.medworm.com/index.php?rid=5163125&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnk1214726767274m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Laparoscopic gastrectomy is widely used as a minimally invasive surgery for gastric cancer. Laparoscopic distal gastrectomy
 must be followed by either a gastroduodenostomy or gastrojejunostomy to restore continuity of the alimentary tract. The intraabdominal
 delta-shaped gastroduodenostomy using endoscopic linear staplers, which was developed by Kanaya et al., is one of the feasible
 reconstructive procedures. However, the clinical results still remain uncertain. In 71 patients treated between February 2008
 and February 2009, we found that anastomotic failure occurred in six patients and there was an intraabdominal abscess around
 the anastomosis in two patients, findings which might be associated with technical pitfalls in the procedure. After considering
 the mecha...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163125</comments>
            <pubDate>Thu, 18 Aug 2011 05:49:27 +0100</pubDate>
            <guid isPermaLink="false">5163125</guid>        </item>
        <item>
            <title>Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience</title>
            <link>http://www.medworm.com/index.php?rid=5163126&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb6015r4259k10412%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The combination of Taxotere (docetaxel), cisplatin, and prolonged-infusion 5-fluorouracil (5-FU) has emerged as an active
 treatment for advanced gastric cancer. However, the regimen proposed by van Cutsem et al. (J Clin Oncol 24:4991–7, 2006) is associated with significant toxicity and therefore alternative schedules are needed. In the present study, patients with
 advanced gastric or esophageal cancer received Taxotere 35&amp;nbsp;mg/m2 and cisplatin 25&amp;nbsp;mg/m2 on day 1, followed by 5-FU 180&amp;nbsp;mg/m2/day as a 7-day prolonged infusion. Drugs were given weekly for 3 consecutive weeks followed by 1&amp;nbsp;week’s rest. Cycles were
 repeated every 4&amp;nbsp;weeks. Overall, a total of 110 cycles were administered to 27 patients (median age 63&amp;nbsp;years, range 40–78&amp;nbsp;...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5163126</comments>
            <pubDate>Wed, 17 Aug 2011 05:55:12 +0100</pubDate>
            <guid isPermaLink="false">5163126</guid>        </item>
        <item>
            <title>Single-institute prospective trial of laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5132806&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2117701v5737582%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;An adequate training program, including site visits by expert surgeons, in conjunction with basic laparoscopy skills and solid
 backgrounds in open gastrectomy from the perspective of the trainees are currently key to the successful and safe implementation
 of LAG. Whether the procedure is oncologically feasible remains to be confirmed by long-term follow-up.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0079-4Authors
		Yoshinari Mochizuki, Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, JapanYasuhiro Kodera, Department of Surgery II, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550 JapanMichitaka Fujiwara, Department of Surgery II, Nagoya University School of Medicine, 65 Tsuruma...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132806</comments>
            <pubDate>Sat, 13 Aug 2011 06:14:41 +0100</pubDate>
            <guid isPermaLink="false">5132806</guid>        </item>
        <item>
            <title>Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5132805&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqw13vm4x416412mk%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Inconsistency exists in the reporting of patient characteristics, the characteristics themselves, and the use of stratification
 factors in clinical trials for AGC. A consensus set of important patient characteristics and strata may be necessary to conduct
 and interpret quality randomized studies.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0083-8Authors
		Kohei Shitara, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, JapanJunko Ikeda, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, JapanChihiro Kondo, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132805</comments>
            <pubDate>Sat, 13 Aug 2011 06:14:41 +0100</pubDate>
            <guid isPermaLink="false">5132805</guid>        </item>
        <item>
            <title>Prophylactic bursectomy at radical gastrectomy for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5132807&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhp73517245340472%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s10120-011-0084-7Authors
		Cuneyt Kayaalp, Department of General Surgery, Turgut Ozal Medical Center, Inonu University, 44315 Malatya, TurkeyAydemir Olmez, Department of General Surgery, Yuzuncu Yil University, Van, TurkeyTurgut Piskin, Department of General Surgery, Turgut Ozal Medical Center, Inonu University, 44315 Malatya, Turkey
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132807</comments>
            <pubDate>Fri, 12 Aug 2011 06:12:03 +0100</pubDate>
            <guid isPermaLink="false">5132807</guid>        </item>
        <item>
            <title>Extended lymph node dissection for gastric cancer from a European perspective</title>
            <link>http://www.medworm.com/index.php?rid=5132808&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1671244402h85041%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s10120-011-0081-xAuthors
		Johan L. Dikken, Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300 RC Leiden, The NetherlandsMarcel Verheij, Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsAnnemieke Cats, Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsEdwin P. M. Jansen, Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsHenk H. Hartgrink, Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300 RC Leiden, The NetherlandsCornelis J. H. van de Velde, Depar...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132808</comments>
            <pubDate>Fri, 12 Aug 2011 06:12:02 +0100</pubDate>
            <guid isPermaLink="false">5132808</guid>        </item>
        <item>
            <title>How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5132809&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07t0q3273380lv0q%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The agreement between pre-operative TNM staging by imaging scans and post-operative staging by pathology is not perfect and
 may affect treatment decisions. Operator dependence and heterogeneity of data may account for the variations in staging performance.
 Physicians should consider this discrepancy when creating their treatment plans.
 
 
 
 
	Content Type Journal ArticlePages 1-16DOI 10.1007/s10120-011-0069-6Authors
		Rajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaCaitlin Mcgregor, Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, CanadaLaercio Lourenco, Department of Surgery, Universidade...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132809</comments>
            <pubDate>Fri, 12 Aug 2011 06:12:01 +0100</pubDate>
            <guid isPermaLink="false">5132809</guid>        </item>
        <item>
            <title>Discrepancies in histologic diagnoses of early gastric cancer between biopsy and endoscopic mucosal resection specimens</title>
            <link>http://www.medworm.com/index.php?rid=5110462&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9283000072026708%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A biopsy diagnosis of borderline lesions or undifferentiated type cancer is more likely to disagree with the diagnosis from
 ER specimens. Endoscopic characteristics should be considered together with the biopsy diagnosis to determine the treatment
 strategy for these lesions.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0075-8Authors
		Madoka Takao, Division of Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Suntougun, Shizuoka, 411-8777 JapanNaomi Kakushima, Division of Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Suntougun, Shizuoka, 411-8777 JapanKohei Takizawa, Division of Endoscopy, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Suntougun, Shizuoka, 411-8777 JapanMasaki Tanaka, Division of En...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5110462</comments>
            <pubDate>Thu, 04 Aug 2011 15:33:22 +0100</pubDate>
            <guid isPermaLink="false">5110462</guid>        </item>
        <item>
            <title>A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=5098547&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1n06744pn6v63315%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The presence of IFCCs appears to increase the risk of peritoneal recurrence and is associated with worse overall survival
 in gastric cancer patients. Further incorporation of peritoneal cytology in clinical decision-making in gastric cancer depends
 on the development of a consistently accurate and rapid IFCC detection method.
 
 
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s10120-011-0071-zAuthors
		Pierre-Anthony Leake, Department of Surgery, University of Toronto, Toronto, ON, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaLaercio Lourenco, Department of Surgery, Universidade Federal de Sao...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5098547</comments>
            <pubDate>Tue, 02 Aug 2011 05:54:08 +0100</pubDate>
            <guid isPermaLink="false">5098547</guid>        </item>
        <item>
            <title>Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study</title>
            <link>http://www.medworm.com/index.php?rid=5064209&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb1635482621t518w%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our outcome data support the clinical validity of ESD without additional surgical resection for SM1-GCs that meet the expanded
 criteria.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0076-7Authors
		Yoji Sanomura, Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Science, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 JapanShiro Oka, Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 JapanShinji Tanaka, Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 JapanIkue Noda, Department of Medicine and Molecular Science, Hiroshima University Graduate School of Biomedical Science, 1-2-3 Kasumi, Minami-ku, Hir...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064209</comments>
            <pubDate>Fri, 22 Jul 2011 17:04:52 +0100</pubDate>
            <guid isPermaLink="false">5064209</guid>        </item>
        <item>
            <title>Multivisceral resection for gastric cancer: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5064210&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3608146tx7289256%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Gastrectomy with MVR can be safely pursued in patients with locally advanced gastric cancer to achieve an R0 resection. MVR
 may not be beneficial in patients with extensive nodal disease.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0074-9Authors
		Savtaj S. Brar, Division of Surgical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Suite T2-60, 2075 Bayview Ave, Toronto, ON M4N 3M5, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaLavanya Yohanathan, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaCalvin Law, Divisi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064210</comments>
            <pubDate>Fri, 22 Jul 2011 17:04:51 +0100</pubDate>
            <guid isPermaLink="false">5064210</guid>        </item>
        <item>
            <title>Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials</title>
            <link>http://www.medworm.com/index.php?rid=5064211&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2332685840rg637%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chemotherapy for gastric cancer has been advancing fairly well. It has been indicated that not only advances in first-line
 chemotherapy but also those in second-line chemotherapy have contributed to the prolongation of overall survival. The Arbeitsgemeinschaft
 Internistische Onkologie (AIO) study supports the idea that second-line chemotherapy is appropriate in patients with a good
 general condition. Also, the Japan Clinical Oncology Group (JCOG) integral analysis suggests that advances have been made
 in second-line chemotherapy. However, most recently reported studies of second-line chemotherapy have been conducted as small-scale
 phase II or retrospective trials. No randomized control trial to establish standard treatment has been reported. Which regimen
 is the m...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064211</comments>
            <pubDate>Fri, 22 Jul 2011 17:04:49 +0100</pubDate>
            <guid isPermaLink="false">5064211</guid>        </item>
        <item>
            <title>Erratum to: p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population</title>
            <link>http://www.medworm.com/index.php?rid=5064212&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq22166566ul73462%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s10120-011-0077-6Authors
		Hye-Rim Song, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaSun-Seog Kweon, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaHee Nam Kim, Genome Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, KoreaJin-Mei Piao, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaWoo-Jun Yun, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaJin-Su Choi, Depart...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064212</comments>
            <pubDate>Thu, 21 Jul 2011 18:10:06 +0100</pubDate>
            <guid isPermaLink="false">5064212</guid>        </item>
        <item>
            <title>Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm</title>
            <link>http://www.medworm.com/index.php?rid=5040680&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx55620162m074647%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study suggests that CS occurs with an incidence of 7.1% after ESD for gastric lesions, and the factors associated with
 post-ESD CS include tumor size and location, and procedural duration.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0073-xAuthors
		Hyuk Lee, Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, 134 Shinchon-dong, Sodaemun-gu, Seoul 120-752, KoreaKyung Seok Cheoi, Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, 134 Shinchon-dong, Sodaemun-gu, Seoul 120-752, KoreaHyunsoo Chung, Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroen...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5040680</comments>
            <pubDate>Thu, 14 Jul 2011 16:50:19 +0100</pubDate>
            <guid isPermaLink="false">5040680</guid>        </item>
        <item>
            <title>Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5010469&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01310wjw48234011%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A paucity of literature exists regarding the QOL of surgically managed gastric cancer patients. Prospectively designed studies
 using credible QOL measures are necessary to better inform the treatment decision-making process for these patients.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0070-0Authors
		Alyson L. Mahar, Department of Community Health and Epidemiology, Queen’s University, Kingston, CanadaNatalie G. Coburn, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, CanadaPaul J. Karanicolas, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USARaymond Viola, Department of Community Health and Epidemiology, Queen’s University, Kingston, CanadaLucy K. Helyer, Department of Surgery, Dalhou...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5010469</comments>
            <pubDate>Mon, 04 Jul 2011 16:17:07 +0100</pubDate>
            <guid isPermaLink="false">5010469</guid>        </item>
        <item>
            <title>Negative trial results are important to understand the mechanisms of multimodality therapy in gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4999868&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg6362qur13r4711l%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s10120-011-0061-1Authors
		Christoph Schuhmacher, Department of Surgery, Technische Universität München, Munich, Germany
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4999868</comments>
            <pubDate>Thu, 30 Jun 2011 09:39:32 +0100</pubDate>
            <guid isPermaLink="false">4999868</guid>        </item>
        <item>
            <title>Safety and feasibility of S-1 adjuvant chemotherapy for gastric cancer in elderly patients</title>
            <link>http://www.medworm.com/index.php?rid=4994107&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy36v24x736543173%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results suggest that S-1 adjuvant chemotherapy for gastric cancer is safe and feasible, regardless of the age of the
 patient; especially for elderly patients who could be candidates for clinical trials.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0068-7Authors
		Toru Aoyama, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakaki Yoshikawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakafumi Watanabe, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTsutomu Hayashi, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4994107</comments>
            <pubDate>Wed, 29 Jun 2011 10:50:59 +0100</pubDate>
            <guid isPermaLink="false">4994107</guid>        </item>
        <item>
            <title>Gastric linitis plastica: which role for surgical resection?</title>
            <link>http://www.medworm.com/index.php?rid=4994106&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffth429688j82w056%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;After primary surgery, GLP showed a poor prognosis without regard to the extent or type of resection. The failure of surgical
 treatment related mainly to the peritoneal spread of the disease. Specifically designed multimodality treatment protocols
 should be tested in this setting.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0063-zAuthors
		Corrado Pedrazzani, Unit of Surgical Oncology, Department of Human Pathology and Oncology, Istituto Toscano Tumouri, University of Siena and ITT, Siena, ItalyDaniele Marrelli, Unit of Surgical Oncology, Department of Human Pathology and Oncology, Istituto Toscano Tumouri, University of Siena and ITT, Siena, ItalyFabio Pacelli, Department of Digestive Surgery, Catholic University of Rome, Rome, ItalyMaria ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4994106</comments>
            <pubDate>Wed, 29 Jun 2011 10:50:59 +0100</pubDate>
            <guid isPermaLink="false">4994106</guid>        </item>
        <item>
            <title>Usefulness of transnasal endoscopy where endoscopic submucosal dissection is difficult</title>
            <link>http://www.medworm.com/index.php?rid=4946957&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fej1947664n127555%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In conclusion, the TN-E was safe and effective for use inside the DB. ESD using the TN-E contributed to accurate pathological
 diagnosis, because the size of the resected specimen was sufficient to prevent the burning effect caused by the ESD.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0065-xAuthors
		Masakatsu Nakamura, Department of Gastroenterology, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 JapanTomoyuki Shibata, Department of Gastroenterology, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 JapanTomomitsu Tahara, Department of Gastroenterology, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 JapanDaisuke Yoshioka, Department of Gastroent...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4946957</comments>
            <pubDate>Tue, 14 Jun 2011 05:57:12 +0100</pubDate>
            <guid isPermaLink="false">4946957</guid>        </item>
        <item>
            <title>Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=4946958&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw12258230035n450%2F</link>
            <description>We report a 75-year-old woman who suffered multiple metachronous osteosclerotic bone metastases 4&amp;nbsp;years after a distal gastrectomy
 for early gastric cancer (EGC). The primary tumor was a poorly differentiated adenocarcinoma, which had invaded the submucosal
 layer, and only one lymph node metastasis was noted. To the best of our knowledge, cases of EGC combined with metachronous
 osteosclerotic multiple bone and bone marrow metastases that respond to chemoradiotherapy are very rare. In this case, the
 multiple bone metastases were diagnosed 4&amp;nbsp;years after surgery. The patient’s metastatic tumor was successfully treated using
 S-1, paclitaxel, and camptothecin, with subsequent irradiation. The patient survived for 24&amp;nbsp;months after the treatment, without
 having any major sym...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4946958</comments>
            <pubDate>Tue, 14 Jun 2011 05:57:11 +0100</pubDate>
            <guid isPermaLink="false">4946958</guid>        </item>
        <item>
            <title>A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4938492&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn188753470029626%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Despite evolving preoperative imaging techniques, diagnostic laparoscopy continues to be of substantial value in staging patients
 with gastric cancer and in avoiding unnecessary laparotomy. The current data support DL for all patients with advanced gastric
 cancer.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10120-011-0047-zAuthors
		Pierre-Anthony Leake, Department of Surgery, University of Toronto, Toronto, ON, CanadaRoberta Cardoso, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaRajini Seevaratnam, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaLaercio Lourenco, Department of Surgery, Universidade Federal de Sao Paulo, Sao Paulo, BrazilLucy Helyer, Department of Surgery, D...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938492</comments>
            <pubDate>Sat, 11 Jun 2011 06:37:43 +0100</pubDate>
            <guid isPermaLink="false">4938492</guid>        </item>
        <item>
            <title>Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4938493&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F66u7270nhr78441u%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This perioperative treatment was safe and feasible for StIVGC but failed to show a survival benefit. In patients with StIVGC
 with Cy1 alone this treatment resulted in a better prognosis.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0066-9Authors
		Seiji Satoh, Kyoto University Surgical Oncology Group, Kyoto, JapanHiroshi Okabe, Kyoto University Surgical Oncology Group, Kyoto, JapanSatoshi Teramukai, Translational Research Center, Kyoto University Hospital, Kyoto, JapanSuguru Hasegawa, Kyoto University Surgical Oncology Group, Kyoto, JapanNobuhiro Ozaki, Kyoto University Surgical Oncology Group, Kyoto, JapanShugo Ueda, Kyoto University Surgical Oncology Group, Kyoto, JapanAyumi Tsuji, Translational Research Informatics Center, Kobe, JapanSatom...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938493</comments>
            <pubDate>Sat, 11 Jun 2011 06:37:42 +0100</pubDate>
            <guid isPermaLink="false">4938493</guid>        </item>
        <item>
            <title>Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early gastric cancer in patients 80 years of age or older</title>
            <link>http://www.medworm.com/index.php?rid=4938494&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw412458v6j10263q%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ESD is safe for the treatment of EGC in patients 80&amp;nbsp;years of age or older. Both curative ESD and additional surgery after
 noncurative ESD may contribute to the extension of life expectancy.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0067-8Authors
		Nobutsugu Abe, Department of Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611 JapanTakuji Gotoda, Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, JapanToshiaki Hirasawa, Endoscopy Division, Cancer Institute Hospital, Tokyo, JapanShu Hoteya, Department of Gastroenterology, Toranomon Hospital, Tokyo, JapanKenji Ishido, Department of Gastroenterology, Kitasato University East Hospital, Kanagawa, JapanYo...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938494</comments>
            <pubDate>Sat, 11 Jun 2011 06:37:41 +0100</pubDate>
            <guid isPermaLink="false">4938494</guid>        </item>
        <item>
            <title>Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4938495&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5534198295wj1400%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We detected 7 cases of leptomeningeal carcinomatosis in 126 patients with peritoneal dissemination of gastric cancer who received
 combined systemic and intraperitoneal chemotherapy. Leptomeningeal carcinomatosis was diagnosed 79–1540&amp;nbsp;days after the diagnosis
 of the primary gastric cancer. Patients presenting with various neurological symptoms were diagnosed by cerebrospinal fluid
 (CSF) cytology and radiological imaging. Irradiation to the whole brain and spine was performed in 4 patients, and provided
 palliation and increased survival for 1 patient. Intrathecal chemotherapy and drainage of CSF was performed in 1 patient each,
 but produced no significant clinical benefit in either of them. Survival after the diagnosis of leptomeningeal carcinomatosis
 was bet...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4938495</comments>
            <pubDate>Sat, 11 Jun 2011 06:37:39 +0100</pubDate>
            <guid isPermaLink="false">4938495</guid>        </item>
        <item>
            <title>A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4914528&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe8u3451532652r61%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The combination of weekly DO demonstrated a well-tolerated profile with moderate activity in the treatment of advanced gastric
 cancer. Further studies of the combination together with a fluoropyrimidine are warranted.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0060-2Authors
		Jen-Shi Chen, Division of Hematology-Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanYen-Yang Chen, Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanJen-Sheng Huang, Division of Hematology-Oncology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, TaiwanKun-Yun Yeh, Division of Hematology-Oncology, Department of Interna...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4914528</comments>
            <pubDate>Tue, 07 Jun 2011 15:51:39 +0100</pubDate>
            <guid isPermaLink="false">4914528</guid>        </item>
        <item>
            <title>Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4896259&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj4007v2440015747%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Decreased NKG2D expression on NK cells may be one of the key mechanisms responsible for NK cell dysfunction in gastric cancer.
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0059-8Authors
		Hiroaki Saito, Division of Surgical Oncology, Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504 JapanTomohiro Osaki, Division of Surgical Oncology, Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504 JapanMasahide Ikeguchi, Division of Surgical Oncology, Department of Surgery, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504 Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896259</comments>
            <pubDate>Mon, 30 May 2011 16:57:04 +0100</pubDate>
            <guid isPermaLink="false">4896259</guid>        </item>
        <item>
            <title>Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma)</title>
            <link>http://www.medworm.com/index.php?rid=4854904&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F42838577u55w3621%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This retrospective study identified undifferentiated-type adenocarcinoma as the only risk factor for recurrence in stage Ib
 gastric cancer patients. Although randomized controlled studies are necessary, stage Ib gastric cancer patients with this
 identified recurrence risk factor would be candidates for adjuvant chemotherapy.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0051-3Authors
		Takashi Yokoyama, Department of Surgery, Hoshigaoka Kouseinenkin Hospital, 4-8-1 Hoshigaoka, Hirakata, Osaka 573-8511, JapanKiyoshi Kamada, Department of Surgery, Hoshigaoka Kouseinenkin Hospital, 4-8-1 Hoshigaoka, Hirakata, Osaka 573-8511, JapanYoshikazu Tsurui, Department of Surgery, Hoshigaoka Kouseinenkin Hospital, 4-8-1 Hoshigaoka, Hirakata, Osaka 573-8511,...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4854904</comments>
            <pubDate>Wed, 18 May 2011 06:13:50 +0100</pubDate>
            <guid isPermaLink="false">4854904</guid>        </item>
        <item>
            <title>First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4832495&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5404n87728048j28%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The treatment regimen of 5-FU-based chemotherapy for advanced gastric cancer with severe peritoneal metastasis was feasible,
 but its efficacy was not sufficient.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0056-yAuthors
		Satoru Iwasa, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTakako Eguchi Nakajima, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKenichi Nakamura, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center Hospital, Tokyo, JapanAtsuo Takashima, Clinical Trials and Practice Support Division, Center for Cancer Control and Informat...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832495</comments>
            <pubDate>Sat, 14 May 2011 15:54:37 +0100</pubDate>
            <guid isPermaLink="false">4832495</guid>        </item>
        <item>
            <title>The delta-shaped anastomosis in laparoscopic distal gastrectomy: analysis of the initial 100 consecutive procedures of intracorporeal gastroduodenostomy</title>
            <link>http://www.medworm.com/index.php?rid=4832496&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0452m525h7g88x0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The wide lumen of the delta-shaped anastomosis led to early, adequate postoperative oral intake without a significant incidence
 of dumping syndrome. The delta-shaped anastomosis is safe and simple and provides satisfactory postoperative results.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0054-0Authors
		Seiichiro Kanaya, Department of Surgery, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 JapanYuichiro Kawamura, Department of Surgery, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192 JapanHironori Kawada, Department of Surgery, Himeji Medical Center, 68 Hon-machi, Himeji, 670-8520 JapanHironori Iwasaki, Department of Surgery, Himeji Medical C...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832496</comments>
            <pubDate>Sat, 14 May 2011 15:54:36 +0100</pubDate>
            <guid isPermaLink="false">4832496</guid>        </item>
        <item>
            <title>Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery</title>
            <link>http://www.medworm.com/index.php?rid=4832498&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft0p8480667463p98%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our results suggest that the ERAS protocol is useful in patients who undergo elective radical gastrectomy.
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0057-xAuthors
		Takanobu Yamada, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-0815, JapanTsutomu Hayashi, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-0815, JapanHaruhiko Cho, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-0815, JapanTakaki Yoshikawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-0815, JapanHideki Taniguchi, Department of Anesth...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832498</comments>
            <pubDate>Sat, 14 May 2011 15:54:35 +0100</pubDate>
            <guid isPermaLink="false">4832498</guid>        </item>
        <item>
            <title>New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points</title>
            <link>http://www.medworm.com/index.php?rid=4832497&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk736751931p2x787%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s10120-011-0040-6Authors
		Takeshi Sano, The Cancer Institute Hospital, Tokyo, JapanTakashi Aiko, Kagoshima University, Kagoshima, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832497</comments>
            <pubDate>Sat, 14 May 2011 15:54:35 +0100</pubDate>
            <guid isPermaLink="false">4832497</guid>        </item>
        <item>
            <title>Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=4832499&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjw832220wpp63142%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The interim analyses suggest that bursectomy may improve survival and should not be abandoned as a futile procedure until
 more definitive data can be obtained.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0058-9Authors
		Junya Fujita, Department of Surgery, Toyonaka Municipal Hospital, Toyonaka, JapanYukinori Kurokawa, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanTomoyuki Sugimoto, Department of Biomedical Statistics, Osaka University Graduate School of Medicine, Osaka, JapanIsao Miyashiro, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, JapanShohei Iijima, Department of Surgery, Minoh City Hospital, Minoh, JapanYutaka Kimura, Department of Surge...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832499</comments>
            <pubDate>Sat, 14 May 2011 15:54:34 +0100</pubDate>
            <guid isPermaLink="false">4832499</guid>        </item>
        <item>
            <title>Japanese classification of gastric carcinoma: 3rd English edition</title>
            <link>http://www.medworm.com/index.php?rid=4832500&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fruh340h1413j7771%2F</link>
            <description>Content Type Journal ArticlePages 1-12DOI 10.1007/s10120-011-0041-5Authors
		Japanese Gastric Cancer Association, Association office, First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto, 602-0841 Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832500</comments>
            <pubDate>Sat, 14 May 2011 05:48:13 +0100</pubDate>
            <guid isPermaLink="false">4832500</guid>        </item>
        <item>
            <title>Japanese gastric cancer treatment guidelines 2010 (ver. 3)</title>
            <link>http://www.medworm.com/index.php?rid=4832501&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F12838416614jqqh1%2F</link>
            <description>Content Type Journal ArticlePages 1-11DOI 10.1007/s10120-011-0042-4Authors
		Japanese Gastric Cancer Association, Association Office, First Department of Surgery, Kyoto Prefectural University of Medicine, Kawaramachi, Kamigyo-ku, Kyoto 602-0841, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4832501</comments>
            <pubDate>Sat, 14 May 2011 05:48:12 +0100</pubDate>
            <guid isPermaLink="false">4832501</guid>        </item>
        <item>
            <title>Optimal indications of surgical palliation for incurable advanced gastric cancer presenting with malignant gastrointestinal obstruction</title>
            <link>http://www.medworm.com/index.php?rid=4822678&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmgl12p4404t400l1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In AGC patients presenting with GI obstruction, surgical palliation was beneficial in patients with PS of 0–1 and those with
 recurrent disease, in terms of improved QOL and prolonged survival, with acceptable operative morbidity and mortality rates.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0053-1Authors
		Kazumasa Fujitani, Department of Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006 JapanManami Yamada, Department of Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006 JapanMotohiro Hirao, Department of Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006 JapanYukinori Kurokawa, Department of Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822678</comments>
            <pubDate>Wed, 11 May 2011 06:24:04 +0100</pubDate>
            <guid isPermaLink="false">4822678</guid>        </item>
        <item>
            <title>Bacteremia and endotoxemia after endoscopic submucosal dissection for gastric neoplasia: pilot study</title>
            <link>http://www.medworm.com/index.php?rid=4822679&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv3350171h100l463%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In spite of the invasive procedure with massive submucosal exposure to the indigenous bacterial flora, gastric ESD has a low
 risk for bacteremia. Gastric ESD-related endotoxemia may be linked to inflammatory reactions such as those shown by the increase
 of CRP or fever observed after ESD.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0050-4Authors
		Masayuki Kato, Department of Endoscopy, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo, 105-8461 JapanMitsuru Kaise, Department of Endoscopy, The Jikei University School of Medicine, 3-25-8 Nishishinbashi, Minato-ku, Tokyo, 105-8461 JapanToru Obata, Microbial Chemistry Center, Microbial Chemistry Research Foundation, Tokyo, JapanJin Yonezawa, Department of Gastroe...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4822679</comments>
            <pubDate>Wed, 11 May 2011 06:24:03 +0100</pubDate>
            <guid isPermaLink="false">4822679</guid>        </item>
        <item>
            <title>Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary</title>
            <link>http://www.medworm.com/index.php?rid=4783255&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2360431m4h4714w6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that SLN mapping with blue dye alone represents a safe procedure that seems to be adaptable for non-obese
 patients undergoing open surgery for gastric cancer in the Eastern European region. The procedure has high sensitivity and
 specificity, especially in cases of T1 and T2 tumors.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0048-yAuthors
		Dezső Tóth, Department of General Surgery, Kenézy Teaching Hospital, 2-26 Bartók Street, Debrecen, 4043 HungaryZsolt Kincses, Department of General Surgery, Kenézy Teaching Hospital, 2-26 Bartók Street, Debrecen, 4043 HungaryJános Plósz, Department of Internal Medicine, Kenézy Teaching Hospital, 2-26 Bartók Street, Debrecen, 4043 HungaryMiklós Török, Department of Patholo...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783255</comments>
            <pubDate>Mon, 02 May 2011 15:56:30 +0100</pubDate>
            <guid isPermaLink="false">4783255</guid>        </item>
        <item>
            <title>Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery</title>
            <link>http://www.medworm.com/index.php?rid=4783254&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft6631238lk422768%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Based on these findings, mE-PASS might be useful for medical decision-making and for assessing the quality of care in elective
 surgery for gastric carcinoma.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0052-2Authors
		Yoshio Haga, Institute for Clinical Research, National Hospital Organization Kumamoto Medical Center, 1-5 Ninomaru, Kumamoto, 860-0008 JapanYasuo Wada, Department of Surgery, National Hospital Organization Himeji Medical Center, Himeji, JapanHitoshi Takeuchi, Department of Surgery, National Hospital Organization Iwakuni Clinical Center, Iwakuni, JapanKoji Ikejiri, Department of Surgery, National Hospital Organization Kyushu Medical Center, Fukuoka, JapanMasakazu Ikenaga, Department of Surgery, National Hospital Organization Osak...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783254</comments>
            <pubDate>Mon, 02 May 2011 15:56:30 +0100</pubDate>
            <guid isPermaLink="false">4783254</guid>        </item>
        <item>
            <title>A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4783256&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr5013272214h7332%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These data demonstrate that KLF6-SV1 is an important regulator of the growth, migration, invasion, and survival of gastric
 cancer cells, and downregulation of KLF6-SV1 by siRNA may offer a new potential gene therapy approach for gastric cancer.
 
 
 
 
	Content Type Journal ArticlePages 1-14DOI 10.1007/s10120-011-0049-xAuthors
		Hui Chen, Department of General Surgery, Third Affiliated Hospital of Harbin Medical University, 150040 Harbin, People’s Republic of ChinaLili Chen, Department of General Surgery, Second Affiliated Hospital of Harbin Medical University, 150040 Harbin, People’s Republic of ChinaLingyu Sun, Department of General Surgery, Fourth Affiliated Hospital of Harbin Medical University, 150040 Harbin, People’s Republic of ChinaHongqun Zhen, Departm...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4783256</comments>
            <pubDate>Mon, 02 May 2011 14:58:06 +0100</pubDate>
            <guid isPermaLink="false">4783256</guid>        </item>
        <item>
            <title>Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4768833&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9643964003277467%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Patients with early-stage cancer actually benefit from 1/2 gastrectomy rather than the typical 2/3 gastrectomy. B-1 reconstruction
 is appropriate for patients with large gastric remnants, and intra-corporeal reconstruction in experienced hands is associated
 with no apparent disadvantages, while offering a favorable cosmetic result.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0046-0Authors
		Eiji Nomura, Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, 569-8686 JapanSang-Woong Lee, Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigaku-Machi, Takatsuki, 569-8686 JapanGeorge Bouras, Department of General and Gastroenterological Surgery, Osaka Medical ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4768833</comments>
            <pubDate>Mon, 25 Apr 2011 16:43:25 +0100</pubDate>
            <guid isPermaLink="false">4768833</guid>        </item>
        <item>
            <title>Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK/ERK and JAK2-signaling pathways in gastric cancer cells</title>
            <link>http://www.medworm.com/index.php?rid=4749084&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6037242474773034%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Gastrin promoter may be the transcriptional target of CagA, and CagA activates the gastrin promoter to up-regulate gastrin
 mRNA expression through the MEK/ERK and JAK1-signaling pathway in gastric cancer cells.
 
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10120-011-0044-2Authors
		Jianjiang Zhou, Affiliated Hospital, Guiyang Medical University, No. 9, Beijiang Road, Guiyang, 550004 ChinaYuan Xie, Molecular Biology Key Laboratory, Guiyang Medical University, Guiyang, 550004 ChinaYan Zhao, Molecular Biology Key Laboratory, Guiyang Medical University, Guiyang, 550004 ChinaShu Wang, Molecular Biology Key Laboratory, Guiyang Medical University, Guiyang, 550004 ChinaYu Li, Molecular Biology Key Laboratory, Guiyang Medical University, Guiyang, 550004 China
	
...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4749084</comments>
            <pubDate>Thu, 21 Apr 2011 06:22:33 +0100</pubDate>
            <guid isPermaLink="false">4749084</guid>        </item>
        <item>
            <title>IL-6 serum levels predict postoperative morbidity in gastric cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=4745318&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy48623586x465056%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our study showed an association between perioperative IL-6 serum levels and postoperative morbidity in gastric cancer patients.
 The IL-6 serum level on the 1st POD was shown to be an independent prognostic factor for both overall complications and infective
 complications.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0039-zAuthors
		Antoni M. Szczepanik, 1st Department of General and Gastrointestinal Surgery, Jagiellonian University Medical College, 40 Kopernika Str, 31-501 Kraków, PolandLucyna Scislo, Department of Clinical Nursing, Faculty of Health Sciences, Institute of Nursing and Midwifery, Jagiellonian University, Kraków, PolandThecla Scully, Intensive Care Unit, Eastbourne District General Hospital, East Sussex, UKElzbieta Walewska, ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745318</comments>
            <pubDate>Wed, 20 Apr 2011 06:05:15 +0100</pubDate>
            <guid isPermaLink="false">4745318</guid>        </item>
        <item>
            <title>A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)</title>
            <link>http://www.medworm.com/index.php?rid=4745319&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkt287454888881j6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although this study did not achieve the per-protocol definition of activity, the progression-free survival and overall survival
 appeared to be promising, with acceptable tolerability. Thus, MMC/CPT-11 therapy as second-line chemotherapy for fluoropyrimidine-resistant
 advanced gastric cancer presents a potential treatment option in patients with a good PS.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0030-8Authors
		Tetsuya Hamaguchi, Division of Gastrointestinal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKuniaki Shirao, Division of Gastrointestinal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanAtsushi Ohtsu, National Cancer Center Hospital East, Research C...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745319</comments>
            <pubDate>Tue, 19 Apr 2011 07:12:34 +0100</pubDate>
            <guid isPermaLink="false">4745319</guid>        </item>
        <item>
            <title>Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study</title>
            <link>http://www.medworm.com/index.php?rid=4745320&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb25762xnn1306254%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Old age, male gender, previous anti-TB treatment, and gastrectomy were significant risk factors for TB. An increased risk
 of TB incidence after chemotherapy was observed in patients with old TB pattern chest films initially, suggesting an interaction
 between chest film patterns and chemotherapy.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0037-1Authors
		Shiang-Fen Huang, Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, Taipei, Taiwan, ROCChung-Pin Li, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROCJia-Yih Feng, Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd., Beitou District, T...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745320</comments>
            <pubDate>Tue, 19 Apr 2011 07:12:33 +0100</pubDate>
            <guid isPermaLink="false">4745320</guid>        </item>
        <item>
            <title>Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4687091&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyp4018828612781l%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A weekly PCF regimen is promising for advanced gastric cancer, although it is associated with moderate hematological and minimal
 non-hematological toxicities.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0043-3Authors
		Takuo Hara, Department of Surgery, Kouseiren Takaoka Hospital, 5-10 Eiraku-cho, Takaoka, 933-8555 JapanKazuhiro Nishikawa, Department of Surgery, Osaka General Medical Center, Osaka, JapanMitsuaki Sakatoku, Department of Surgery, Tonami General Hospital, Tonami, JapanKoji Oba, Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido University, Sapporo, JapanJunichi Sakamoto, Department of Social Life Science, Nagoya University, Nagoya, JapanKenji Omura, Department of Surgery, Yamanaka-spa Medica...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687091</comments>
            <pubDate>Tue, 05 Apr 2011 09:47:42 +0100</pubDate>
            <guid isPermaLink="false">4687091</guid>        </item>
        <item>
            <title>p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population</title>
            <link>http://www.medworm.com/index.php?rid=4687092&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg3p8l705082068l0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that the Pro/Pro genotype is associated with modest increases in the risks of gastric cancer and colorectal
 cancer in a Korean population.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0034-4Authors
		Hye-Rim Song, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaSun-Seog Kweon, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, Gwangju, 501-746 South KoreaHee Nam Kim, Genome Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, KoreaJin-Mei Piao, Department of Preventive Medicine, Chonnam National University Medical School, 5, Hak 1-dong, Dong-gu, G...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687092</comments>
            <pubDate>Sat, 02 Apr 2011 05:48:21 +0100</pubDate>
            <guid isPermaLink="false">4687092</guid>        </item>
        <item>
            <title>Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1</title>
            <link>http://www.medworm.com/index.php?rid=4687093&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F03v075421p033l88%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The macroscopic tumor diameter was the most important prognostic factor for survival in patients with stage II/III gastric
 cancer who underwent D2 gastrectomy followed by adjuvant S-1 chemotherapy. Prognostic factors can be affected by adjuvant
 chemotherapy.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0038-0Authors
		Toru Aoyama, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakaki Yoshikawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakafumi Watanabe, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTsutomu Hayashi, Department of Gastrointestinal ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687093</comments>
            <pubDate>Sat, 02 Apr 2011 05:48:19 +0100</pubDate>
            <guid isPermaLink="false">4687093</guid>        </item>
        <item>
            <title>Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4687094&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp72629hj36v0572p%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The CASP8 −652 6N ins/del and the CASP9 −1263 A&amp;gt;G polymorphisms were observed to play a protective role in GC predisposition.
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0045-1Authors
		Emmanouil Liamarkopoulos, 1st Surgical Department, “Tzaneion” Hospital, Piraeus, GreeceMaria Gazouli, Department of Biology, School of Medicine, University of Athens, Michalakopoulou 176, 11527 Athens, GreeceGerasimos Aravantinos, 3rd Clinic of Pathology-Oncology, “Agioi Anargyroi” Oncology Hospital, Athens, GreeceNikolaos Tzanakis, Second Propaedeutic Surgical Department, Laiko University Hospital, Athens, GreeceGeorge Theodoropoulos, 1st Department of Propedeutic Surgery, Athens Medical School, Hippokration University Hospital, Athens, GreeceSpy...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4687094</comments>
            <pubDate>Sat, 02 Apr 2011 05:48:16 +0100</pubDate>
            <guid isPermaLink="false">4687094</guid>        </item>
        <item>
            <title>Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany</title>
            <link>http://www.medworm.com/index.php?rid=4645342&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F03j56n3564j0g880%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Significant differences of clinical and surgical parameters exist between gastric cancer patients treated in Poland and Germany.
 In addition to established independent prognostic factors, we found that survival improved with each additionally resected
 lymph node.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0036-2Authors
		Radoslaw Jaworski, Department of Surgical Oncology, Medical University of Gdansk, Gdańsk, PolandElfriede Bollschweiler, Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937 Cologne, GermanyArnulf H. Holscher, Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Str. 62, 50937 Cologne, GermanyStefan P. Monig, Department of General, Visceral and Ca...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4645342</comments>
            <pubDate>Fri, 25 Mar 2011 18:51:53 +0100</pubDate>
            <guid isPermaLink="false">4645342</guid>        </item>
        <item>
            <title>Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4637201&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6255795x6318tw75%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This analysis suggests that some clinicopathologic factors might be helpful in identifying the subgroup of patients most likely
 to benefit from third-line chemotherapy for advanced gastric cancer.
 
 
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s10120-011-0032-6Authors
		Hyun Jeong Shim, Department of Hematology-Oncology, Chonnam National University Medical School, Gwangju, 501-757 KoreaJu Young Yun, Department of Hematology-Oncology, Chonnam National University Medical School, Gwangju, 501-757 KoreaJun Eul Hwang, Department of Hematology-Oncology, Chonnam National University Medical School, Gwangju, 501-757 KoreaWoo Kyun Bae, Department of Hematology-Oncology, Chonnam National University Medical School, Gwangju, 501-757 KoreaSang Hee Cho, Department of He...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4637201</comments>
            <pubDate>Tue, 22 Mar 2011 18:08:05 +0100</pubDate>
            <guid isPermaLink="false">4637201</guid>        </item>
        <item>
            <title>Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden</title>
            <link>http://www.medworm.com/index.php?rid=4637200&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe287u871822tn925%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The observed increased risks of gastric cancer among first-generation immigrants compared to those in Swedes suggest the role
 of childhood environmental exposure in the risk of this disease.
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0033-5Authors
		Seyed Mohsen Mousavi, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, GermanyJan Sundquist, Centers for Primary Care Research, Lund University, Malmö, SwedenKari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4637200</comments>
            <pubDate>Tue, 22 Mar 2011 18:08:05 +0100</pubDate>
            <guid isPermaLink="false">4637200</guid>        </item>
        <item>
            <title>Gastric adenocarcinoma with rhabdoid morphology</title>
            <link>http://www.medworm.com/index.php?rid=4611698&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr3131242426l7225%2F</link>
            <description>We describe a woman aged 86&amp;nbsp;years who had an advanced gastric tumor with lymph node metastasis. The
 tumor mostly showed a diffuse arrangement with a small glandular region. The tumor cells were non-cohesive and had polygonal
 morphology with eccentric vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm, i.e. they showed rhabdoid
 features. Immunohistochemically, the rhabdoid tumor cells were strongly positive for cytokeratins and vimentin. However, a
 candidate tumor suppressor gene of rhabdoid tumors, the INI1 gene, showed no mutations or loss of expression in the tumor cells. Although ERRTs typically have an aggressive clinical
 course, the patient was still alive without any evidence of recurrence or metastasis at 26&amp;nbsp;months after surgery. The rhabdoid
 f...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611698</comments>
            <pubDate>Wed, 16 Mar 2011 11:51:03 +0100</pubDate>
            <guid isPermaLink="false">4611698</guid>        </item>
        <item>
            <title>Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum</title>
            <link>http://www.medworm.com/index.php?rid=4611699&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F917l2610034p767v%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Cetiri every two weeks is a convenient and well-tolerated second-line regimen in GEC patients. A promising effect was seen
 in patients with PS 0-1 and in patients who developed a rash.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0031-7Authors
		Katrine R. Schoennemann, Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, DenmarkJon K. Bjerregaard, Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, DenmarkTine P. Hansen, Department of Clinical Pathology, Odense University Hospital, Odense C, DenmarkKarin De Stricker, Department of Clinical Pathology, Odense University Hospital, Odense C, DenmarkMorten F. Gjerstorff, Department of Hematology, Center for Cancer Immune Therapy (C...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4611699</comments>
            <pubDate>Wed, 16 Mar 2011 11:51:02 +0100</pubDate>
            <guid isPermaLink="false">4611699</guid>        </item>
        <item>
            <title>New method of endoscopic full-thickness resection: a pilot study of non-exposed endoscopic wall-inversion surgery in an ex vivo porcine model</title>
            <link>http://www.medworm.com/index.php?rid=4581960&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj0572737lw028j43%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The indications for endoscopic full-thickness resection (EFTR) are limited because transmural communication during the entire
 procedure, causing tumor dissemination into the abdominal space, is inevitable. We invented a new method of EFTR without transmural
 communication, and explored its feasibility in an ex vivo porcine model. Three explanted porcine stomachs were used. First,
 markings around a model lesion were made with a flexible endoscope, and 0.9% normal saline with indigocarmine was injected
 into the submucosa around the markings. Second, a circumferential sero-muscular incision was made from the outside with an
 electrocautery knife, guided by the color of the submucosal injection and intragastric navigation with the endoscope. Third,
 the muscle layer was ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4581960</comments>
            <pubDate>Fri, 11 Mar 2011 06:58:46 +0100</pubDate>
            <guid isPermaLink="false">4581960</guid>        </item>
        <item>
            <title>Blowin’ in the wind</title>
            <link>http://www.medworm.com/index.php?rid=4562132&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl3x5003228008221%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s10120-011-0029-1Authors
		Shigeaki Yoshida, Aomori Prefectural Hospital Administration, 2-1-1 Higashi Tsukurimichi, Aomori, 030-8553 Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562132</comments>
            <pubDate>Fri, 04 Mar 2011 11:03:30 +0100</pubDate>
            <guid isPermaLink="false">4562132</guid>        </item>
        <item>
            <title>General perioperative management of gastric cancer patients at high-volume centers</title>
            <link>http://www.medworm.com/index.php?rid=4562133&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F47871u77k260n84x%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The general management of gastric cancer in 14 high-volume centers was not so different among the centers. The general management
 protocols noted here are expected to provide useful information for perioperative care.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0012-xAuthors
		Hye Seong Ahn, Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul, 110-744 KoreaJeong Hwan Yook, Department of Surgery, Asan Medical Center, Seoul, KoreaCho Hyun Park, Department of Surgery, Catholic University Seoul St. Mary Hospital, Seoul, KoreaYoung Kyu Park, Department of Surgery, Chonnam National University Hospital, Gwangju, KoreaWansik Yu, Department of Surgery, Kyungpook Nation...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562133</comments>
            <pubDate>Fri, 04 Mar 2011 11:03:29 +0100</pubDate>
            <guid isPermaLink="false">4562133</guid>        </item>
        <item>
            <title>Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=4562134&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb60rj264513j813k%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our study suggests survival benefits of debulking gastrectomy or gastrectomy plus metastasectomy in gastric cancer patients
 with distant metastases receiving systemic chemotherapy. Prolonged disease-free survival was observed after complete resection
 (gastrectomy plus metastasectomy) that may lead to cure in some patients. Well-designed prospective trials of the role of
 multidisciplinary approaches combining chemotherapy and surgery are needed to confirm the observations of our study.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0015-7Authors
		Ki Hwan Kim, Department of Internal Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707, Republic of KoreaKeun-Wook Lee, Department of In...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562134</comments>
            <pubDate>Fri, 04 Mar 2011 11:03:26 +0100</pubDate>
            <guid isPermaLink="false">4562134</guid>        </item>
        <item>
            <title>The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification</title>
            <link>http://www.medworm.com/index.php?rid=4541691&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq4j4uh855301805q%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The 7th UICC classification for lymph node metastasis is thought to be a more reliable prognostic factor for gastric cancer
 than the 6th classification.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0024-6Authors
		Sumin Chae, Department of Surgery, Mok-dong Hospital, Ewha Womans University, School of Medicine, 911-1 Mok-dong, Yangcheon-ku Seoul, 158-710, KoreaAnbok Lee, Department of Surgery, Mok-dong Hospital, Ewha Womans University, School of Medicine, 911-1 Mok-dong, Yangcheon-ku Seoul, 158-710, KoreaJoo-Ho Lee, Department of Surgery, Mok-dong Hospital, Ewha Womans University, School of Medicine, 911-1 Mok-dong, Yangcheon-ku Seoul, 158-710, Korea
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541691</comments>
            <pubDate>Mon, 28 Feb 2011 17:12:33 +0100</pubDate>
            <guid isPermaLink="false">4541691</guid>        </item>
        <item>
            <title>Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment</title>
            <link>http://www.medworm.com/index.php?rid=4541692&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82xg73377x46gu32%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s10120-011-0018-4Authors
		Hiroya Takiuchi, Cancer Chemotherapy Center, Osaka Medical College, 2-7 Daigaku-Cho, Takatsuki, Osaka 569-8686, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541692</comments>
            <pubDate>Mon, 28 Feb 2011 17:12:32 +0100</pubDate>
            <guid isPermaLink="false">4541692</guid>        </item>
        <item>
            <title>Efficacy of NiTi Hand CAC™ 30 for jejunojejunostomy in gastric cancer surgery: results from a multicenter prospective randomized trial</title>
            <link>http://www.medworm.com/index.php?rid=4541693&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv2563xn5k528782l%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our prospective multicenter clinical trial showed that the use of the NiTi Hand CAC™ 30 for jejunojejunostomy in gastric cancer
 surgery was feasible and could reduce anastomosis time. However, considering that there were two cases of leakage, extended
 use of the NiTi Hand CAC™ 30 should be carefully applied.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0010-zAuthors
		Hoon Hur, Department of Surgery, School of Medicine, Ajou University Hospital, San-5, Wonchon-Dong, Yeongtong-Gu, Suwon 422-749, KoreaHyung Ho Kim, Department of Surgery, Seoul National University Bundang Hospital, Seongnam, KoreaWoo Jin Hyung, Department of Surgery, Yonsei University Severance Hospital, Seoul, KoreaGyu Seok Cho, Department of Surgery, Soonchunhyang Univers...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541693</comments>
            <pubDate>Wed, 23 Feb 2011 23:13:14 +0100</pubDate>
            <guid isPermaLink="false">4541693</guid>        </item>
        <item>
            <title>Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach</title>
            <link>http://www.medworm.com/index.php?rid=4541694&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc0866l201n8234k4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Total gastrectomy or proximal gastrectomy is usually performed either as an open procedure or laparoscopically for the treatment
 of early gastric cancer (EGC) in the upper stomach. However, quality of life after either total or proximal gastrectomy is
 not so satisfactory. The authors report a novel surgical procedure, laparoscopy-assisted subtotal gastrectomy (LAsTG), by
 which a very small remnant stomach is preserved, for the surgery of selected EGCs in the upper stomach. Twenty-three patients
 with EGC in the upper stomach underwent LAsTG. After lymph node dissection and mobilization of the stomach, the stomach was
 transected about 2&amp;nbsp;cm proximal to the tumor and a very small remnant stomach was preserved. An anvil was inserted transorally
 into the remnant st...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4541694</comments>
            <pubDate>Wed, 23 Feb 2011 23:13:13 +0100</pubDate>
            <guid isPermaLink="false">4541694</guid>        </item>
        <item>
            <title>Does the article, “Mass screening for gastric cancer: how to select patients for endoscopic examination,” satisfy criteria of scientific quality?</title>
            <link>http://www.medworm.com/index.php?rid=4522959&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg3rq78k1453303q5%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s10120-011-0026-4Authors
		Masao Kobayakawa, Department of Gastroenterology, National Center for Global Health and Medicine Hospital, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655 Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522959</comments>
            <pubDate>Tue, 22 Feb 2011 17:07:18 +0100</pubDate>
            <guid isPermaLink="false">4522959</guid>        </item>
        <item>
            <title>Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4522960&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8k808316j1022243%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Each of the four agent classes (FU, platinum agents, taxanes, and irinotecan) appears to be independently associated with
 improved OS in patients with AGC regardless of timing. This result suggests the importance of developing strategies which
 make these active agents available to all patients with AGC to prolong OS.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0019-3Authors
		Kohei Shitara, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, JapanKeitaro Matsuo, Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, JapanAyako Mizota, Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681,...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522960</comments>
            <pubDate>Tue, 22 Feb 2011 06:55:55 +0100</pubDate>
            <guid isPermaLink="false">4522960</guid>        </item>
        <item>
            <title>Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=4522962&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx0494g62121w2830%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results support the existence of a small but significant survival benefit of oxaliplatin over cisplatin. Oxaliplatin is
 associated with less toxicity and better tolerability, especially in older patients and when used in two-drug, bi-weekly regimens.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0007-7Authors
		Francesco Montagnani, Oncology Unit, Department of Medicine, S. Giuseppe Hospital, AUSL 11, Viale Boccaccio, 50053 Empoli, Florence ItalyGina Turrisi, Oncology Unit, Department of Medicine, S. Giuseppe Hospital, AUSL 11, Viale Boccaccio, 50053 Empoli, Florence ItalyClaudio Marinozzi, Department of Oncology, AUSL 10, Florence, ItalyCamillo Aliberti, Interventional Radiology Unit, Department of Radiology, Delta Hospital, AUSL, Ferrara...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522962</comments>
            <pubDate>Tue, 22 Feb 2011 06:55:53 +0100</pubDate>
            <guid isPermaLink="false">4522962</guid>        </item>
        <item>
            <title>Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)</title>
            <link>http://www.medworm.com/index.php?rid=4522961&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff7163574ml28x380%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although IRI-S achieved longer median survival than S-1 monotherapy and was well tolerated, it did not show significant superiority
 in this study.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0009-5Authors
		Hiroyuki Narahara, Division of Clinical Oncology, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551 JapanHiroyasu Iishi, Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanHiroshi Imamura, Department of Surgery, Sakai Municipal Hospital, Osaka, JapanAkira Tsuburaya, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, JapanKeisho Chin, Department of Medical Oncology, Cancer Institute Hospital, Tokyo, ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4522961</comments>
            <pubDate>Tue, 22 Feb 2011 06:55:53 +0100</pubDate>
            <guid isPermaLink="false">4522961</guid>        </item>
        <item>
            <title>Treatment for gastric carcinoma in the oldest old patients</title>
            <link>http://www.medworm.com/index.php?rid=4513711&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgp55j6441471v748%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Postoperative outcomes were relatively acceptable. Surgery may be feasible and beneficial even for extremely aged patients
 85&amp;nbsp;years and older, except for those with a performance status of 4.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0022-8Authors
		Shunji Endo, Department of Surgery, National Hospital Organization Kure Medical Center/Chugoku Cancer Center, 3-1 Aoyama-cho, Kure, Hiroshima 737-0023, JapanYukinobu Yoshikawa, Department of Surgery, National Hospital Organization Kure Medical Center/Chugoku Cancer Center, 3-1 Aoyama-cho, Kure, Hiroshima 737-0023, JapanNobutaka Hatanaka, Department of Surgery, National Hospital Organization Kure Medical Center/Chugoku Cancer Center, 3-1 Aoyama-cho, Kure, Hiroshima 737-0023, JapanHarumi Tom...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513711</comments>
            <pubDate>Sat, 19 Feb 2011 07:17:40 +0100</pubDate>
            <guid isPermaLink="false">4513711</guid>        </item>
        <item>
            <title>A novel procedure for Roux-en-Y reconstruction following laparoscopy-assisted distal gastrectomy: transoral placement of anvil and intracorporeal gastrojejunostomy via umbilical mini-laparotomy</title>
            <link>http://www.medworm.com/index.php?rid=4513713&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq37680x81074p463%2F</link>
            <description>We describe herein our procedures for Roux-en-Y reconstruction using a transoral anvil following laparoscopy-assisted distal
 gastrectomy (LADG). The procedure consists of three technical processes: transoral placement of the anvil with the head pre-tilted,
 extracorporeal preparation of the Roux-en-Y limb, and intracorporeal gastrojejunostomy with a circular stapler introduced
 via an umbilical mini-laparotomy. We applied the procedure to 33 patients with early gastric cancer between December 2008
 and June 2010. None of the patients suffered from surgical complications related either to the transoral placement of the
 anvil or the anastomoses. The postoperative wound appearance was much less conspicuous than that of conventional laparoscopic
 distal gastrectomy, because our procedure nee...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513713</comments>
            <pubDate>Sat, 19 Feb 2011 07:17:35 +0100</pubDate>
            <guid isPermaLink="false">4513713</guid>        </item>
        <item>
            <title>Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2</title>
            <link>http://www.medworm.com/index.php?rid=4513712&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg321142466120292%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;There was no benefit in overall and relapse-free survival with this adjuvant chemotherapy regimen for patients with macroscopically
 serosa-positive gastric cancer after curative resection.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0027-3Authors
		Isao Miyashiro, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanHiroshi Furukawa, Department of Surgery, Sakai City Hospital, Sakai, JapanMitsuru Sasako, Department of Surgery, Hyogo College of Medicine, Nishinomiya, JapanSeiichiro Yamamoto, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, JapanAtsushi Nashimoto, Department of Surgery, Niigata Cancer Center Hospital, Niigata, JapanToshifusa Nakajima, Department of Sur...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4513712</comments>
            <pubDate>Sat, 19 Feb 2011 07:17:35 +0100</pubDate>
            <guid isPermaLink="false">4513712</guid>        </item>
        <item>
            <title>Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients</title>
            <link>http://www.medworm.com/index.php?rid=4503141&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj18h0n222qu83656%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Patients with tumors localized on the greater curvature and Borrmann type 4 cancers might obtain relatively high survival
 benefits from lymph node dissection at the splenic hilus by splenectomy.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0028-2Authors
		Toshiyuki Kosuga, Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 JapanDaisuke Ichikawa, Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 JapanKazuma Okamoto, Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 JapanShuhei Komats...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503141</comments>
            <pubDate>Thu, 17 Feb 2011 17:03:32 +0100</pubDate>
            <guid isPermaLink="false">4503141</guid>        </item>
        <item>
            <title>Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=4503142&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhq7203128t023p71%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Since April 2010, the Japanese Public Health Insurance System has covered the costs incurred for performing 18F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) imaging for patients with advanced gastric cancer. The aim
 of this review was to evaluate the clinical impact of PET for patients with gastric cancer. A systematic literature search
 was performed in PubMed/MEDLINE using the keywords “gastric cancer” and “PET” to search for relevant articles published from
 January 2000 to September 2010. The clinical impact of selected articles was assessed by the authors to evaluate the following:
 (a) tumor staging, (b) diagnosis for recurrent disease, (c) evaluation of treatment response, and (d) screening for gastric
 cancer. FDG uptake increases in pap...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503142</comments>
            <pubDate>Thu, 17 Feb 2011 17:03:29 +0100</pubDate>
            <guid isPermaLink="false">4503142</guid>        </item>
        <item>
            <title>Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4503144&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmn5x035715284751%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Weekly i.v. paclitaxel is a safe and effective chemotherapeutic regimen based on validated CBR-CG criteria.
 
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s10120-011-0016-6Authors
		Haruhiko Imamoto, Department of Surgery, Kinki University, Osaka, JapanKoji Oba, Translational Research and Clinical Trial Center Hokkaido University Hospital, Hokkaido University, Sapporo, JapanJunichi Sakamoto, Young Leaders’ Program in Health-Care Administration, Department of Social-Life Science, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showaku, Nagoya, 466-8550 JapanHiroyasu Iishi, Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanHiroyuki Narahara, Department of Clinical Oncology, Hiroshima Univ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503144</comments>
            <pubDate>Thu, 17 Feb 2011 07:06:23 +0100</pubDate>
            <guid isPermaLink="false">4503144</guid>        </item>
        <item>
            <title>Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway</title>
            <link>http://www.medworm.com/index.php?rid=4503143&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw94p58762k237556%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The application of a pathway involving ESD resulted in a significant decrease in the rate of potentially avoidable surgery,
 highlighting the advantages associated with performing ESD.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0008-6Authors
		Satoru Nonaka, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanIchiro Oda, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTeruo Nakaya, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanChika Kusano, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanHaruhisa Suzuki, Endoscopy Division, National Cancer Center ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503143</comments>
            <pubDate>Thu, 17 Feb 2011 07:06:23 +0100</pubDate>
            <guid isPermaLink="false">4503143</guid>        </item>
        <item>
            <title>Adjuvant chemoradiation for resected gastric cancer: a 10-year experience</title>
            <link>http://www.medworm.com/index.php?rid=4503145&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl62510uu4h145760%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Postoperative chemoradiation is safe and late toxicity is usually mild in extent. Results were comparable to the Intergroup
 0116 study. R0 resection is of utmost importance and radiotherapy should best be delivered by conformal techniques.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0011-yAuthors
		Amy T. Y. Chang, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong KongWai Tong Ng, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong KongAda L. Y. Law, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong KongKi Man Ku, Department of Clinical Oncology, Pamela Youde Nethersole Eastern ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503145</comments>
            <pubDate>Thu, 17 Feb 2011 07:06:21 +0100</pubDate>
            <guid isPermaLink="false">4503145</guid>        </item>
        <item>
            <title>Depth-predicting score for differentiated early gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4503146&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc3186x2v51208g02%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The depth-predicting score could be useful in the decisions on treatment strategy for differentiated M-SM1 early gastric cancers.
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0002-zAuthors
		Seiichiro Abe, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanIchiro Oda, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTaichi Shimazu, Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, JapanTetsu Kinjo, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKazuhiro Tada, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4503146</comments>
            <pubDate>Thu, 17 Feb 2011 07:06:20 +0100</pubDate>
            <guid isPermaLink="false">4503146</guid>        </item>
        <item>
            <title>Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification</title>
            <link>http://www.medworm.com/index.php?rid=4496172&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn69j26560m784332%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In most patients, the planned 1-year adjuvant S-1 therapy for stage II or III gastric cancer could be completed by modifying
 the dose reduction and treatment schedule.
 
 
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s10120-011-0003-yAuthors
		Satoru Iwasa, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanYasuhide Yamada, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTakeo Fukagawa, Gastric Surgery Division, National Cancer Center Hospital, Tokyo, JapanTakako Eguchi Nakajima, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKen Kato, Gastrointestinal Oncology Div...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496172</comments>
            <pubDate>Wed, 16 Feb 2011 07:01:59 +0100</pubDate>
            <guid isPermaLink="false">4496172</guid>        </item>
        <item>
            <title>Nutritional recovery after open and laparoscopic gastrectomies</title>
            <link>http://www.medworm.com/index.php?rid=4496173&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5w2u24147m0121r1%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Both fat and muscle mass reductions were responsible for the body weight loss during the first postoperative month, whereas
 loss of fat mass contributed to further weight loss after that period. Enhanced recovery of muscle mass at 6&amp;nbsp;months after
 laparoscopic surgery suggests the benefit of this surgery, among other factors.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0021-9Authors
		Shavkat Abdiev, Department of Surgery II, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, JapanYasuhiro Kodera, Department of Surgery II, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, JapanMichitaka Fujiwara, Department of Surgery II, Nagoya University Gradu...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496173</comments>
            <pubDate>Wed, 16 Feb 2011 07:01:56 +0100</pubDate>
            <guid isPermaLink="false">4496173</guid>        </item>
        <item>
            <title>Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1</title>
            <link>http://www.medworm.com/index.php?rid=4496175&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc7150mh7965j825n%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results suggested that the survival did not reach the level expected for first-line chemotherapy. The histological type
 was a significant prognosticator in patients who experienced recurrence after adjuvant S-1 therapy and thereafter received
 palliative chemotherapy.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0020-xAuthors
		Toru Aoyama, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakaki Yoshikawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTakafumi Watanabe, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-0815 JapanTsutomu Hayashi, Department of Ga...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496175</comments>
            <pubDate>Wed, 16 Feb 2011 07:01:55 +0100</pubDate>
            <guid isPermaLink="false">4496175</guid>        </item>
        <item>
            <title>Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4496174&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flr03110812278465%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Gastric PNEC patients with distant metastasis had poor outcomes. Regimens containing cisplatin plus irinotecan produced a
 good response in gastric PNEC.
 
 
 
 
	Content Type Journal ArticlePages 1-5DOI 10.1007/s10120-011-0025-5Authors
		Natsuko Tsuda Okita, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanKen Kato, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanDaisuke Takahari, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanYoshinori Hirashima, Gastrointestinal Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanTakako E. Nak...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4496174</comments>
            <pubDate>Wed, 16 Feb 2011 07:01:55 +0100</pubDate>
            <guid isPermaLink="false">4496174</guid>        </item>
        <item>
            <title>Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas</title>
            <link>http://www.medworm.com/index.php?rid=4429984&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr37776r2j17876wx%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Determination of endoscopic macroscopic type may be useful in accurately diagnosing early EGJ adenocarcinoma invasion depth.
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0001-0Authors
		Ichiro Oda, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanSeiichiro Abe, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanChika Kusano, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanHaruhisa Suzuki, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanSatoru Nonaka, Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanShiget...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429984</comments>
            <pubDate>Thu, 27 Jan 2011 17:38:02 +0100</pubDate>
            <guid isPermaLink="false">4429984</guid>        </item>
        <item>
            <title>Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4415740&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2511386h210736t5%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Evaluation of not only the expression of E-cadherin, but also the coexpression of E-cadherin and Slug in patients with preserved
 E-cadherin expression would be useful for predicting malignant properties of gastric cancer.
 
 
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s10120-011-0004-xAuthors
		Yasuto Uchikado, Department of Surgical Oncology, Digestive Surgery, Graduate School of Medicine, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, 890-8520 JapanHiroshi Okumura, Department of Surgical Oncology, Digestive Surgery, Graduate School of Medicine, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, 890-8520 JapanSumiya Ishigami, Department of Surgical Oncology, Digestive Surgery, Graduate School of Medicine, Kagoshima University, Sakuragaoka 8-35-1,...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4415740</comments>
            <pubDate>Thu, 27 Jan 2011 17:38:02 +0100</pubDate>
            <guid isPermaLink="false">4415740</guid>        </item>
        <item>
            <title>Trans-vaginal specimen extraction following totally laparoscopic subtotal gastrectomy in early gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4412520&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F72723p0413781h62%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The present technique may be a safe and feasible operative procedure for some limited groups of elderly female patients with
 early gastric cancer.
 
 
 
 
	Content Type Journal ArticlePages 1-6DOI 10.1007/s10120-011-0006-8Authors
		Sang-Ho Jeong, Department of Surgery, Gyeongsang National University Hospital, 90 Chilam-dong, Jinju, Gyeongsang South Province 660-702, South KoreaYoung-Joon Lee, Department of Surgery, Gyeongsang National University Hospital, 90 Chilam-dong, Jinju, Gyeongsang South Province 660-702, South KoreaWon Jun Choi, Department of Obstetrics and Gynecology, Gyeongsang National University Hospital, Jinju, South KoreaWon Young Paik, Department of Obstetrics and Gynecology, Gyeongsang National University Hospital, Jinju, South KoreaChi-Young Jeong, ...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4412520</comments>
            <pubDate>Mon, 24 Jan 2011 18:02:30 +0100</pubDate>
            <guid isPermaLink="false">4412520</guid>        </item>
        <item>
            <title>Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer</title>
            <link>http://www.medworm.com/index.php?rid=4401292&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft228513282l1j803%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The coexistence of gastric cancer with duodenal ulcer has been found empirically to be rare, but why it is rare is difficult
 to explain satisfactorily. To elucidate this question, we carried out a literature review of the subject. The frequency with
 which the two diseases coexist is 0.1–1.7%, and the main factor associated with both gastric cancer and duodenal ulcer is
 Helicobacter pylori infection. However, there are marked differences between the disorders of hyperchlorhydria in duodenal ulcer, and hypochlorhydria
 in gastric cancer. The most acceptable view of the reason for the difference may be that the acquisition of H. pylori infection occurs mainly in childhood, so that the time of acquisition of atrophic gastritis may be the most important, and
 if atrophi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401292</comments>
            <pubDate>Wed, 19 Jan 2011 16:58:22 +0100</pubDate>
            <guid isPermaLink="false">4401292</guid>        </item>
        <item>
            <title>Endoscopic resection of undifferentiated-type gastric carcinoma: an extreme step to be restrained?</title>
            <link>http://www.medworm.com/index.php?rid=4231169&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft62ux417253lx114%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s10120-010-0578-8Authors
		Takeshi Sano, Department of Gastroenterological Surgery, Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550 Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291
	
		Journal Volume Volume 13
	
		Journal Issue Volume 13, Number 4 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231169</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:21 +0100</pubDate>
            <guid isPermaLink="false">4231169</guid>        </item>
        <item>
            <title>Lymph node metastasis from undifferentiated-type mucosal gastric cancer satisfying the expanded criteria for endoscopic resection based on routine histological examination</title>
            <link>http://www.medworm.com/index.php?rid=4231170&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Far11823356w008n4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 58-year-old woman was found to have a 45-mm abdominal mass adjacent to the pancreas on screening ultrasonography, and subsequent
 esophagogastroduodenoscopy revealed a small gastric cancer (13 mm in diameter). We initially performed endoscopic submucosal
 dissection (ESD), and routine histological examination of the specimen sectioned at 2-mm intervals revealed a poorly differentiated
 adenocarcinoma and signet ring cell carcinoma confined to the mucosa without lymphatic-vascular capillary involvement or ulceration.
 These findings satisfied the expanded criteria for ESD we reported recently. We next performed laparoscopic excisional biopsy
 of the abdominal mass, and histological examination with immunohistochemical staining revealed a metastatic lymph node (LN)
 res...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231170</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:19 +0100</pubDate>
            <guid isPermaLink="false">4231170</guid>        </item>
        <item>
            <title>A Western single-center experience with endoscopic submucosal dissection for early gastrointestinal cancers</title>
            <link>http://www.medworm.com/index.php?rid=4231171&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr2t3667656810n81%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Endoscopic submucosal dissection (ESD) has gained worldwide acceptance as a treatment for early gastrointestinal cancers (EGICs).
 However, the management of these tumors in the Western world is still mainly surgical. Our aim was to evaluate the safety
 and feasibility of ESD at a European center. Based on the knowledge transferred by one of the most experienced Japanese institutions,
 we conducted a pilot study on 25 consecutive patients with EGICs located in the esophagus (n = 3), stomach (n = 7), duodenum (n = 1), and colon (n = 14) at our tertiary center over a 2-year-period. The main outcome measurements were complete (R0) resection, as well as
 en-bloc resection and the management of complications. The R0 and en-bloc resection rates were 100% and 84%, respectively...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231171</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:16 +0100</pubDate>
            <guid isPermaLink="false">4231171</guid>        </item>
        <item>
            <title>Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703)</title>
            <link>http://www.medworm.com/index.php?rid=4231172&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9h801260mg1952v7%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This trial confirmed the safety of LADG performed by credentialed surgeons in terms of the incidence of anastomotic leakage
 or pancreatic fistula formation. A phase III trial (JCOG 0912) to confirm the noninferiority of LADG to an open gastrectomy
 in terms of overall survival is ongoing.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0565-0Authors
		Hitoshi Katai, Gastric Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanMitsuru Sasako, Department of Surgery, Hyogo College of Medicine, Hyogo, JapanHaruhiko Fukuda, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, JapanKenichi Nakamura, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, JapanNa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231172</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:14 +0100</pubDate>
            <guid isPermaLink="false">4231172</guid>        </item>
        <item>
            <title>Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=4231173&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqm7050724757380r%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Although S-1 monotherapy showed moderate efficacy in elderly (≥76 years) patients with AGC, patients in this age group showed
 higher incidences of severe toxicities than the younger patients.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0566-zAuthors
		Takahiro Tsushima, Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka, 411-8777 JapanShuichi Hironaka, Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka, 411-8777 JapanNarikazu Boku, Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka, 411-8777 JapanNozomu Machida, Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimo...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231173</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:12 +0100</pubDate>
            <guid isPermaLink="false">4231173</guid>        </item>
        <item>
            <title>No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese</title>
            <link>http://www.medworm.com/index.php?rid=4231175&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F06q8497737876870%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our study did not reproduce the association between gastric cancer risk and the TLR2 -196 to -174del polymorphism in Japanese. Further examinations with sufficient numbers of study subjects are required to
 verify our findings.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0567-yAuthors
		Asahi Hishida, Department of Preventive Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550 JapanKeitaro Matsuo, Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, JapanYasuyuki Goto, Department of Preventive Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550 JapanMariko Naito, Department of Preventive Medicine, Nagoya University Gradu...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231175</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:09 +0100</pubDate>
            <guid isPermaLink="false">4231175</guid>        </item>
        <item>
            <title>Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?</title>
            <link>http://www.medworm.com/index.php?rid=4231174&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F041608647l21j731%2F</link>
            <description>In conclusion, a more detailed understanding of the differential
 roles of malignant cell-derived and hostderived cytokines at different stages of the malignant process could, consequently,
 open new avenues for the manipulation of cytokine expression and function in cancer immunotherapy for gastric cancer.
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0568-xAuthors
		Hironori Tsujimoto, Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, 359-8513 JapanSatoshi Ono, Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, 359-8513 JapanTakashi Ichikura, Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, 359-8513 JapanYusuke Matsumoto, Department of Surgery, National Defense Medical College, 3-2 Nami...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231174</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:09 +0100</pubDate>
            <guid isPermaLink="false">4231174</guid>        </item>
        <item>
            <title>Socioeconomic status and gastric cancer survival in Japan</title>
            <link>http://www.medworm.com/index.php?rid=4231176&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy323kx7614670484%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These findings suggest that a disparity in survival by occupation exists among Japanese gastric cancer patients, largely due
 to a lower proportion of early disease among the unemployed and manual laborers.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0561-4Authors
		Aya Kuwahara, Department of Food and Nutritional Science, Shuko Junior College, Iwate, JapanRibeka Takachi, Division of Clinical Epidemiology, Tohoku University Graduate School of Medicine, Miyagi, JapanYoshitaka Tsubono, Division of Clinical Epidemiology, Tohoku University Graduate School of Medicine, Miyagi, JapanShizuka Sasazuki, Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, JapanManami Inoue, Epidemiology and P...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231176</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:08 +0100</pubDate>
            <guid isPermaLink="false">4231176</guid>        </item>
        <item>
            <title>Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively</title>
            <link>http://www.medworm.com/index.php?rid=4231178&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1x6m6782w828wq3%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The results of the chemosensitivity test were correlated with the patient outcome. Therefore, such results might be useful
 for individualizing cancer chemotherapy and for determining future indications for postoperative adjuvant chemotherapy.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0564-1Authors
		Kentaro Maejima, Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533 JapanAkira Tokunaga, Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, 211-8533 JapanTeruo Kiyama, Department of Surgery, Nippon Medical School, Tokyo, JapanHitoshi Kanno, Department of Surgery, Nippon Medical School, Tokyo...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231178</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:07 +0100</pubDate>
            <guid isPermaLink="false">4231178</guid>        </item>
        <item>
            <title>A case of small undifferentiated intramucosal gastric cancer with lymph node metastasis</title>
            <link>http://www.medworm.com/index.php?rid=4231177&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1q3hvn2263818xm%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Early gastric cancer (EGC) has a favorable prognosis after surgical gastrectomy. For intramucosal EGC with little risk of
 lymph node metastasis, endoscopic mucosal resection (EMR) is an accepted treatment method. Herein we document a noteworthy
 case of small undifferentiated gastric cancer with nodal metastasis. A 60-year-old Japanese woman underwent gastrectomy with
 D2 lymph node dissection for the treatment of EGC in the lower gastric body. Histological examination revealed that signet-ring
 cell carcinoma was located in approximately one-third of the superficial portion of the mucosal layer, with a tumor size of
 13 mm. No lymphatic invasion, venous invasion, or fibrosis was observed in the submucosal layer. This case had nodal metastasis
 and was finally diagnose...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231177</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:07 +0100</pubDate>
            <guid isPermaLink="false">4231177</guid>        </item>
        <item>
            <title>Online First publication of Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4231179&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F754454865m3j8733%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s10120-010-0579-7Authors
		Yuko Kitagawa, Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 JapanHubert J. Stein, Department of Surgery, Klinikum Nürnberg Nord, Nuremberg, GermanySpringer, Tokyo, Japan
	

	
		Journal Gastric CancerOnline ISSN 1436-3305Print ISSN 1436-3291
	
		Journal Volume Volume 13
	
		Journal Issue Volume 13, Number 4 (Source: Gastric Cancer)</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4231179</comments>
            <pubDate>Thu, 02 Dec 2010 22:28:05 +0100</pubDate>
            <guid isPermaLink="false">4231179</guid>        </item>
        <item>
            <title>Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial</title>
            <link>http://www.medworm.com/index.php?rid=3948339&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm721j45w141203h2%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This is the first randomized comparison of two of the newer cytostatic drugs in GC therapy. No differences favoring either
 arm T or arm C were found with respect to response rate, OS, or toxicity. The median OS of 11 months indicates that sequential
 administration of the two combinations is effective and is similar to triple combinations. Thus, comparable efficacy to platinum
 combinations appears to be obtained with newer, less toxic regimens when given sequentially.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0553-4Authors
		Michael Gubanski, Department of Oncology, Karolinska University Hospital at Södersjukhus, Sjukhusbacken 10, SE-118 83 Stockholm, SwedenAnders Johnsson, Department of Oncology, University of Lund, Lund, SwedenEva Fernebro, Depa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948339</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:57 +0100</pubDate>
            <guid isPermaLink="false">3948339</guid>        </item>
        <item>
            <title>Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance</title>
            <link>http://www.medworm.com/index.php?rid=3948340&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F57jnj17115117080%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Geminin expression might reflect the biological nature of gastric intramucosal neoplasms and could be a possible prognostic
 marker in advanced intestinal-type gastric carcinomas.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0558-zAuthors
		Kohei Shomori, Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503 JapanKeisuke Nishihara, Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503 JapanTakayuki Tamura, Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503 Japa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948340</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:54 +0100</pubDate>
            <guid isPermaLink="false">3948340</guid>        </item>
        <item>
            <title>Lymph node dissection in the resection of gastric cancer: Review of existing evidence</title>
            <link>http://www.medworm.com/index.php?rid=3948341&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftg24k1327114g24v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gastric cancer is one of the leading causes of cancer-related death worldwide. Surgery is the only curative therapy for localized
 gastric cancer, but the extent of regional lymphadenectomy has been a matter of considerable debate. Extended resections that
 are regarded as standard procedures in some Asian countries, including Japan and Korea, have not been shown to be as effective
 in Western countries. The extent of lymphadenectomy for advanced gastric cancer has been studied in many prospective randomized
 controlled trials. On the other hand, patients with early gastric cancer have an excellent survival rate (&amp;gt;90%) after radical
 surgery. Lymph node metastasis from early gastric cancer is relatively infrequent. Therefore, it might be practical to perform
 less in...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948341</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:30 +0100</pubDate>
            <guid isPermaLink="false">3948341</guid>        </item>
        <item>
            <title>Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=3948343&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj7837414117r2056%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A combination of weekly paclitaxel plus S-1 was found to be well tolerated and effective in patients with advanced gastric
 cancer. Further investigation with comparative trials is needed for confirmation.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0548-1Authors
		Yuji Ueda, Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, JapanHisakazu Yamagishi, Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, JapanDaisuke Ichikawa, Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, JapanKazuma Okamoto, Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japa...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948343</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:28 +0100</pubDate>
            <guid isPermaLink="false">3948343</guid>        </item>
        <item>
            <title>The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer</title>
            <link>http://www.medworm.com/index.php?rid=3948342&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1424373711342k4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our results suggest that infection with a virulent H. pylori strain was associated with early-stage gastric cancer and that carcinogenesis was associated with cag PAI-dependent MMP-7 upregulation.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0552-5Authors
		Woo Chul Chung, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, KoreaSung Hoon Jung, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, KoreaKang-Moon Lee, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, KoreaChang Nyol Paik, Department of Internal Medicine, College of Medicine, the Catholic University of Korea, Seoul, KoreaJea Wuk Kawk, Department of Internal Medi...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948342</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:28 +0100</pubDate>
            <guid isPermaLink="false">3948342</guid>        </item>
        <item>
            <title>The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=3948344&amp;cid=s_33402_17_f&amp;fid=33402&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2723l180474xp507%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The presence of ITC in the lymph nodes does not affect the prognosis of patients with gastric cancer who have undergone gastrectomy
 with D2 lymph node dissection.
 
 
 
 
	Content Type Journal ArticleDOI 10.1007/s10120-010-0556-1Authors
		Takeo Fukagawa, Gastric Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045 JapanMitsuru Sasako, Digestive Surgery, Hyogo Medical College, Hyogo, JapanSeiji Ito, Department of Gastrointestinal Surgery, Aichi Cancer Center Hospital, Nagoya, JapanHayao Nakanishi, Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya, JapanHisae Iinuma, Department of Surgery, Teikyo University, Tokyo, JapanShoji Natsugoe, Department of Surgical Oncology, Kagoshima University, Kagoshima...</description>
            <author>Gastric Cancer</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3948344</comments>
            <pubDate>Tue, 07 Sep 2010 20:49:25 +0100</pubDate>
            <guid isPermaLink="false">3948344</guid>        </item>
    </channel>
</rss>

